Exhibit 10.1


 


EXECUTION VERSION


INVESTMENT AGREEMENT


 


THIS INVESTMENT AGREEMENT (this “Agreement”),
dated as of September 11, 2015, is made by and between Trinity Place Holdings Inc., a Delaware corporation (the “Company”)
and MFP Partners, L.P., a Delaware limited partnership (the “Investor”).


 


WHEREAS, the Company proposes to conduct a
rights offering (the “Rights Offering”) by distributing, at no charge, to each holder of record as of the Record
Date (as defined below) of shares (“Shares”) of the Company’s common stock, par value $0.01 per share
(the “Common Stock”), 0.248362 non-transferable rights (the “Rights”), for each Share held
by such shareholder, to purchase Shares;


 


WHEREAS, the Rights will be exercisable for
an aggregate of Five Million (5,000,000) Shares (the “Offered Shares”) and, if exercised in full by each such
holder, will provide gross proceeds to the Company of Thirty Million Dollars ($30,000,000) (the “Aggregate Offering Amount”);


 


WHEREAS, each whole Right will entitle the
holder to purchase one Share (the “Basic Subscription Privilege”) at a price equal to $6.00 per Share (as appropriately
adjusted for any stock split, combination, reorganization, recapitalization, stock dividend, stock distribution or similar event,
the “Exercise Price”), subject to the Cutback (as defined below);


 


WHEREAS, each holder of Rights (other than
the Investor) who exercises all of its Rights will be entitled, on a pro rata basis, to subscribe for additional Shares at the
Exercise Price (the “Over-Subscription Privilege”), to the extent that other holders of Rights do not exercise
all of their respective Basic Subscription Privileges in full, subject to the Cutback;


 


WHEREAS, in order to facilitate the Rights
Offering, the Investor has agreed to subscribe for and purchase, at the Exercise Price, upon expiration of the Rights Offering,
up to 3,333,333 Offered Shares that are not purchased pursuant to the exercise of Rights in the Rights Offering less the
number of Offered Shares purchased by the Investor pursuant to the exercise of its Basic Subscription Privilege, upon the terms
and subject to the conditions set forth herein and subject to the Cutback (the “Backstop Commitment”);


 


WHEREAS, in the event the Investor does not
purchase at least 1,666,667 Shares in the aggregate pursuant to the Backstop Commitment, the Company has agreed to issue and sell
to the Investor at the Exercise Price, and the Investor has agreed to purchase, a number of additional Shares that will result
in the Investor having purchased an aggregate of 1,666,667 Shares under this Agreement (the “Minimum Commitment”);


 


WHEREAS, at the Closing, the Company will
enter into a Registration Rights Agreement with the Investor, substantially in the form of Exhibit A hereto (the “Registration
Rights Agreement”), pursuant to which the Company agrees to register all of the Shares held by the Investor and/or its
Affiliates immediately following the consummation of the transactions contemplated by this Agreement, including all Shares held
by the Investor and/or its Affiliates as of the date hereof;


 




     


     

    

 


WHEREAS, in order to preserve the Company’s
ability to utilize the full benefits of its net operating losses and related tax benefits, the Company may, in its discretion,
reduce the number of Offered Shares issuable to some or all Eligible Holders (as defined below) in the Rights Offering and/or pursuant
to this Agreement, as determined by the Board of Directors in consultation with the Company’s advisors following the Expiration
Time (as defined below), subject to the terms and conditions set forth herein; and


 


WHEREAS, the Board of Directors has unanimously
approved this Agreement, the Rights Offering, each of the other Transaction Agreements and the transactions contemplated hereby
and thereby.


 


NOW, THEREFORE, in consideration of the mutual
promises, agreements, representations, warranties and covenants contained herein, each of the parties hereto hereby agrees as follows:


 


1.          Rights
Offering.


 


(a)          On
the terms and subject to the conditions set forth herein, the Company will distribute, at no charge, 0.248362 Rights to each holder
of record of Common Stock (each, an “Eligible Holder”) for each share of Common Stock held by such holder as
of the close of business on a record date to be determined by the Board of Directors (the “Record Date”). Each
such Right shall be non-transferable. Each whole Right will entitle the holder thereof to purchase, at the election of the holder
thereof, one Share at the Exercise Price, subject to the Cutback, if any. The total number of Rights issued to each Eligible Holder
will be rounded down to the nearest whole number.


 


(b)          The
Rights, including the Basic Subscription Privilege and the Over-Subscription Privilege, may be exercised during a period (the “Rights
Exercise Period”) commencing on the date on which Rights are issued to Eligible Holders (the “Rights Offering
Commencement Date”) and ending at 5:00 p.m. Eastern Daylight Time on a Business Day that shall not be less than twenty
(20) days after the Rights Offering Commencement Date, subject to extension at the reasonable discretion of the Board of Directors,
provided, however, that the Rights Exercise Period shall not be extended by more than thirty (30) days without the
prior written consent of the Investor (the “Expiration Time”). “Business Day” means each
Monday, Tuesday, Wednesday, Thursday and Friday that is not a day on which banking institutions in New York City are generally
authorized or obligated by law or executive order to close.


 


(c)          Each
holder of Rights who wishes to exercise all or a portion of its Rights under the Basic Subscription Privilege shall (i) during
the Rights Exercise Period return a duly executed election form to a subscription agent selected by the Company (the “Subscription
Agent”) electing to exercise all or a portion of the Rights held by such holder (provided that only whole Rights may
be exercised) to purchase one Offered Share for each Right so exercised and (ii) pay an amount equal to the Exercise Price for
each Share that the holder elects to purchase pursuant to the instructions filed with the Rights Offering Registration Statement
(as defined below), and related materials by the specified date to an escrow account established for the Rights Offering. On the
Closing Date or as promptly as practicable thereafter, the Company will issue to each holder of Rights who validly exercised its
Rights the number of Shares to which such holder is entitled based on such exercise, subject to the Cutback.


 




    	 	2	 



     

    

 


 


(d)          In
the event that all of the Offered Shares are not purchased upon exercise of the Basic Subscription Privilege, each holder of Rights
(other than the Investor) who exercises in full its Basic Subscription Privilege will be entitled under the Over-Subscription Privilege
to subscribe for additional Shares at the Exercise Price pursuant to the instructions filed with the Rights Offering Registration
Statement and related materials, subject to the Cutback. If the number of Offered Shares remaining after the exercise of Rights
under the Basic Subscription Privilege (the “Remaining Offered Shares”) is not sufficient to satisfy all requests
for Shares under the Over-Subscription Privileges, the holders who exercised their Over-Subscription Privileges will be allocated
such Remaining Offered Shares in proportion to the product (rounded to the nearest whole number so that the Exercise Price multiplied
by the aggregate number of Offered Shares does not exceed the Aggregate Offering Amount) obtained by multiplying the number of
Offered Shares such holder subscribed for under the Over-Subscription Privilege by a fraction the numerator of which is the number
of Remaining Offered Shares and the denominator of which is the total number of Offered Shares sought to be subscribed for under
the Over-Subscription Privilege by all holders participating in such Over-Subscription Privilege. Rights under the Over-Subscription
Privilege shall be exercised at the same time as Rights under the Basic Subscription Privilege.


 


(e)          The
Company shall notify, or cause the Subscription Agent to notify, the Investor, on each Friday during the Rights Exercise Period
and on each Business Day during the five Business Days immediately prior to the Expiration Time (and any extensions thereto), or
more frequently if reasonably requested by the Investor, of the aggregate number of Rights known by the Company or the Subscription
Agent to have been exercised pursuant to the Rights Offering as of the close of business on the preceding Business Day or the most
recent practicable time before such request, as the case may be.


 


(f)          As
soon as practicable, and in any event within three (3) Business Days, after the Expiration Time, the Company will give the Investor
notice of the number of Offered Shares elected to be purchased by holders of Rights pursuant to validly exercised Rights pursuant
to the Basic Subscription Privilege and the Over-Subscription Privilege (the “Subscribed Shares”), and the number
of Offered Shares issuable pursuant to Rights that were not properly exercised by the holders thereof during the Rights Offering
(the “Unsubscribed Shares”) and the aggregate Exercise Price therefor (a “Purchase Notice”)
or, if there were no Unsubscribed Shares, the fact that there are no Unsubscribed Shares (a “Satisfaction Notice”)
(the date of transmission of a Purchase Notice or a Satisfaction Notice, the “Determination Date”).


 


(g)          Subject
to the Cutback, on the Closing Date (as defined below), and on the terms and subject to the conditions in this Agreement, the Investor
agrees to purchase, and the Company will sell to the Investor, at the Exercise Price, Unsubscribed Shares and, if applicable, additional
Shares, as follows:


 


(i)          The
Investor shall purchase up to 3,333,333 Unsubscribed Shares at the Exercise Price; provided, that such amount shall be reduced
as applicable to give effect to the purchase of any Shares by the Investor under its Basic Subscription Privilege;


 




    	 	3	 



     

    

 


 


(ii)         In
the event the Investor does not purchase at least 1,666,667 Shares pursuant to clause (i) above (the “Minimum Share Allocation”),
the Company shall issue and sell to the Investor at the Exercise Price, and the Investor shall purchase, a number of additional
Shares that will result in the Investor having purchased an amount of Shares in the aggregate under this Agreement (and excluding
any Offered Shares purchased by the Investor in the Rights Offering) equal to the Minimum Share Allocation; and


 


(iii)        Promptly
following the Determination Date, the Investor and the Company shall review and agree on the amount of Shares to be purchased by
the Investor pursuant to the calculations set forth in this paragraph (g) (the “Backstop Shares”).


 


(h)          Notwithstanding
anything to the contrary in this Agreement, the Rights Offering Registration Statement or otherwise, as promptly as practicable
after the Expiration Time the Company, in its good faith discretion and in consultation with its tax advisors, will determine,
to the extent commercially reasonable, whether to effect any reduction in the amount of Subscribed Shares and/or Backstop Shares
as is reasonably necessary in order to preserve the Company’s ability to utilize the full benefits of its net operating losses
and related tax benefits (such reduction, if any, the “Cutback”), subject to the following provisions:


 


(i)          In
making such determination, the Company and its tax advisors will evaluate such factors as they deem reasonable and appropriate,
including, among others, the need for the Company to maintain an appropriate “cushion”, determined by the Company at
its discretion in consultation with its tax advisors, to protect against experiencing an “ownership change” within
the meaning of Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”);


 


(ii)         If
the Company determines to make a Cutback, it will attempt to do so, as nearly as may be practicable, in the following order of
priority:


 


(A)         First,
to reduce the number of Shares that would be otherwise issuable under validly exercised Rights pursuant to the Over-Subscription
Privilege; provided, that the application of the Cutback may be different with respect to different holders of Rights, depending
on the circumstances;


 


(B)         Second,
to reduce the number of Backstop Shares that would be otherwise issuable under Section 1(g)(i), but not below the Minimum Share
Allocation;


 


(C)         Third,
to reduce the number of Shares that would be otherwise issuable under validly exercised Rights pursuant to the Basic Subscription
Privilege; provided, that the application of the Cutback may be different with respect to different holders of Rights, depending
on the circumstances; and


 




    	 	4	 



     

    

 


(D)         Fourth,
to reduce the number of Shares that would be otherwise issuable under Section 1(g)(ii);


 


provided, that prior to making any
Cutback with respect to Investor Shares, the Company will consult with the Investor and consider any reasonable suggestions from
the Investor regarding the application of the Cutback  to the Investor Shares.


 


(i)          The
Investor shall have the right to arrange for one or more of its Affiliates (each, an “Affiliated Purchaser”)
to purchase any Shares issuable to the Investor pursuant to its Backstop Commitment, by written notice to the Company at least
two (2) Business Days prior to the Closing Date, which notice shall be signed by the Investor and each Affiliated Purchaser, and
shall contain a confirmation by the Affiliated Purchaser of the accuracy with respect to it of the representations set forth in
Section 4. In no event will any such arrangement relieve the Investor from its obligations under this Agreement. The term
“Affiliate” shall have the meaning ascribed to such term in Rule 12b-2 under the Securities Exchange
Act of 1934, as amended (the “Exchange Act”), in effect on the date hereof.


 


(j)          The
closing of the purchase of the Shares to be purchased in the Rights Offering and the Shares to be purchased by the Investor hereunder
(the “Closing”) will occur at 10:00 a.m., New York City time, as soon as practicable following the Expiration
Time and after giving effect to the determinations contemplated by paragraphs (f), (g) and (h) above (the “Closing Date”).
The Company and, to the extent applicable, the Investor, shall use commercially reasonable efforts to cause the Closing Date to
occur within seven (7) Business Days following the Expiration Time. Delivery to the Investor of the Shares acquired by the Investor
pursuant to this Agreement and the Rights Offering (the “Investor Shares”) will be made by the Company to the
account of the Investor (or to such other accounts, including the account of an Affiliated Purchaser, as the Investor may designate
in accordance with this Agreement). The documents to be delivered on the Closing Date by or on behalf of the parties hereto and
certificates representing the Investor Shares will be delivered at the offices of Kramer Levin Naftalis & Frankel LLP, on the
Closing Date.


 


(k)          All
Investor Shares will be delivered with any and all issue, stamp, transfer, sales and use, or similar Taxes or duties payable in
connection with such delivery duly paid by the Company.


 


2.          Expense
Reimbursement. On the basis of the representations and warranties herein contained, and in consideration for the Investor’s
Backstop Commitment, the Company will promptly reimburse or pay, as the case may be, on the Closing Date, the reasonable out-of-pocket
costs and expenses incurred by the Investor in connection with the transactions contemplated hereby (including, without limitation,
the Rights Offering, the Rights Offering Registration Statement, the Shelf Registration Statement (as defined in the Registration
Rights Agreement), the Backstop Commitment and the negotiation and execution of the Transaction Agreements) to the extent incurred
on or before the Closing Date (and thereafter all post-closing costs and expenses relating to the transactions contemplated hereby
to the extent incurred within three months of the Closing Date), including reasonable fees and disbursements of counsel to the
Investor (collectively, “Transaction Expenses”). The provision for the payment of the Transaction Expenses is
an integral part of the transactions contemplated by this Agreement and without this provision the Investor would not have entered
into this Agreement.


 




    	 	5	 



     

    

 


 


3.          Representations
and Warranties of the Company. The Company represents and warrants to, and agrees with the Investor, as set forth below. Except
for representations, warranties and agreements that are expressly limited as to their date, each representation, warranty and agreement
is made as of the date hereof and as of the Closing Date after giving effect to the transactions contemplated hereby:


 


(a)          Organization
and Qualification. The Company and each of its Subsidiaries has been duly organized and is validly existing in good standing
under the laws of its respective jurisdiction of incorporation, with the requisite power and authority to own its properties and
conduct its business as currently conducted. Each of the Company and its Subsidiaries has been duly qualified as a foreign corporation
or organization for the transaction of business and is in good standing under the laws of each other jurisdiction in which it owns
or leases properties or conducts any business so as to require such qualification, except to the extent that the failure to be
so qualified or be in good standing has not had and would not reasonably be expected to have, individually or in the aggregate,
a Material Adverse Effect. For the purpose of this Agreement, “Material Adverse Effect” means (i) any material
adverse effect on the business, condition (financial or otherwise) or results of operations of the Company or its Subsidiaries,
taken as a whole, or (ii) any material adverse effect on the ability of the Company, subject to the approvals and other authorizations
set forth in Section 3(g), to consummate the transactions contemplated by this Agreement; provided, however, that
“Material Adverse Effect” shall not include the impact on such business, condition (financial or otherwise),
results of operations or ability to consummate the transactions contemplated by this Agreement arising out of or attributable to,
either alone or in combination with any other change, effect, circumstance, occurrence, event, condition or fact (“Effects”)
(i) Effects that generally affect the industry in which the Company and its Subsidiaries operate, (ii) general economic conditions,
(iii) Effects resulting from changes affecting financial, banking, securities or commodities markets (including in each of clauses
(i), (ii) and (iii) above, any Effects resulting from an outbreak or escalation of hostilities, acts of war or terrorism, political
instability or other national or international calamity, crisis or emergency, or any governmental or other response to any of the
foregoing, in each case whether or not involving the United States), (iv) Effects arising from changes in laws, rules, regulations
or accounting principles, (v) Effects resulting from the announcement of the transactions contemplated hereby or from taking any
action required by the terms and conditions of this Agreement or any of the other agreements or transactions contemplated hereby,
(vi) the historical seasonality of the business of the Company or any Subsidiary or the failure to meet any projections or forecasts
or (vii) any change in the price or trading volume of the Company’s outstanding securities (it being understood that the
facts or occurrences giving rise to or contributing to such change in stock price or trading volume may be deemed to constitute,
or be taken into account in determining whether there has been, or will be, a Material Adverse Effect); except if such Effect results
from, or is attributable to, any of the matters described in clauses (i), (ii), (iii), (iv) or (vi) above and disproportionately
affects the Company and its Subsidiaries, taken as a whole, relative to other businesses in the industry in which the Company and
its Subsidiaries operate (but taking into account for purposes of determining whether a Material Adverse Effect has occurred only
the disproportionate portion of such adverse effect). For the purposes of this Agreement, a “Subsidiary” of
any person means, with respect to such person, any corporation, partnership, joint venture or other legal entity of which such
person (either alone or through or together with any other subsidiary), owns, directly or indirectly, more than 50% of the stock
or other equity interests, has the power to elect a majority of the board of directors or similar governing body, or has the power
to direct the business and policies.


 




    	 	6	 



     

    

 


 


(b)          Corporate
Power and Authority. The Company has the requisite corporate power and authority to enter into, execute and deliver this Agreement
and the Registration Rights Agreement (together, the “Transaction Agreements”), and to perform its obligations
hereunder and thereunder and consummate the transactions contemplated hereby and thereby, including the issuance of the Rights,
the Offered Shares and the Investor Shares. The Company has taken all necessary corporate action required for the due authorization,
execution, delivery and performance by it of this Agreement, including the issuance of the Rights, the Offered Shares and the Investor
Shares.


 


(c)          Execution
and Delivery; Enforceability. Each Transaction Agreement has been, or prior to its execution and delivery at the Closing will
be, duly and validly executed and delivered by the Company, and each such document constitutes, or will constitute, the valid and
binding obligation of the Company, enforceable against the Company in accordance with its terms subject to (i) bankruptcy, insolvency,
moratorium and other similar laws now or hereafter in effect relating to or affecting creditors’ rights generally, and (ii)
general principles of equity (regardless of whether considered in a proceeding at law or in equity).


 


(d)          Authorized
and Issued Capital Stock. The authorized capital stock of the Company consists of 79,999,997 shares of Common Stock, one share
of Series A preferred stock and one share of Series B preferred stock, each with a par value of $0.01 per share, one share of a
class of special stock, par value $0.01 per share, and 40,000,000 shares of a class of designation preferred stock, par value $0.01
per share. At the close of business on September 8, 2015 (the “Capital Structure Date”), (i) 24,728,471 shares
of Common Stock were issued and 20,131,928 shares of Common Stock were outstanding, (ii) one share
of Series A preferred stock, one share of Series B preferred stock and one share of special stock were issued and outstanding,
(iii) 4,596,543 shares of Common Stock were held by the Company in its treasury, and (iv) 1,602,796 shares of Common Stock were
reserved for issuance upon settlement of outstanding restricted stock units (each, an “RSU” and, collectively,
the “RSUs”) granted under any stock-based compensation plan of the Company or otherwise (the “Stock
Plans”). All capital stock or equity interests of each of the Company’s Subsidiaries is owned by the Company. The
issued and outstanding shares of capital stock of the Company and each of its Subsidiaries have been duly authorized and validly
issued and are fully paid and nonassessable, and are not subject to any preemptive rights. Except as set forth in this Section
3(d), at the close of business on the Capital Structure Date, no shares of capital stock or other equity securities or voting
interest in the Company or any of its Subsidiaries were issued, reserved for issuance or outstanding. Since the close of business
on the Capital Structure Date, no shares of capital stock or other equity securities or voting interest in the Company or any of
its Subsidiaries have been issued or reserved for issuance or become outstanding, other than Shares described in this Section
3(d) that have been issued upon the vesting and settlement of RSUs granted under the Stock Plans and other than the shares
to be issued hereunder. Other than as set forth in (i) this Section 3(d), (ii) the Employment Agreement, dated as of October
1, 2013, between the Company and Matthew Messinger (the “CEO Employment Agreement”) (iii) Restricted Stock Unit
Agreements with other employees of the Company (to the extent not yet settled or terminated), (iv) the Company’s certificate
of incorporation and (v) this Agreement, neither the Company nor any of its Subsidiaries is party to or otherwise bound by or subject
to any outstanding option, warrant, call, subscription or other right (including any preemptive right), agreement or commitment
which (w) obligates the Company or any of its Subsidiaries to issue, deliver, sell or transfer, or repurchase, redeem or otherwise
acquire, or cause to be issued, delivered, sold or transferred, or repurchased, redeemed or otherwise acquired, any shares of the
capital stock of, or other equity or voting interests in, the Company or any of its Subsidiaries or any security convertible or
exercisable for or exchangeable into any capital stock of, or other equity or voting interest in, the Company or any of its Subsidiaries,
(x) obligates the Company or any of its Subsidiaries to issue, grant, extend or enter into any such option, warrant, call, right,
security, commitment, contract, arrangement or undertaking, (y) restricts the transfer of any shares of capital stock of the Company
or (z) relates to the voting of any shares of capital stock of the Company or any of its Subsidiaries.


 




    	 	7	 



     

    

 


 


(e)          Issuance.
The Investor Shares to be issued and sold by the Company to the Investor or any Affiliated Purchaser hereunder, when such Shares
are issued and delivered against payment therefor in accordance with the terms hereof, will be duly and validly authorized, fully
paid and non-assessable, free and clear of all Taxes, liens, preemptive rights, rights of first refusal, subscription and similar
rights.


 


(f)          No
Conflict. The distribution of the Rights, the sale, issuance and delivery of the Offered Shares upon exercise of the Rights,
the consummation of the Rights Offering by the Company and the execution and delivery by the Company of the Transaction Agreements
and compliance by the Company with all of the provisions hereof and thereof and the consummation of the transactions contemplated
herein and therein (including issuance and sale of Investor Shares to the Investor) (i) will not, in any material respect, conflict
with, or result in a breach or violation of, any of the terms or provisions of, or constitute a default under (with or without
notice or lapse of time, or both), or result in the acceleration of, or the creation of any lien under, any indenture, mortgage,
deed of trust, loan agreement or other material agreement or instrument to which the Company or any of its Subsidiaries is a party
or by which the Company or any of its Subsidiaries is bound or to which any of the property or assets of the Company or any of
its Subsidiaries is subject, (ii) will not result in any violation of the provisions of the certificate of incorporation or by-laws
or comparable organizational documents of the Company or any of its Subsidiaries, and (iii) subject to the receipt of the consents
and approvals contemplated in Section 3(g), will not result in any violation of, or any termination or impairment of any
rights under, any law, rule or regulation, any license, authorization, injunction, judgment, order, decree, rule or regulation
of any court or governmental agency or body having jurisdiction over the Company or any of its Subsidiaries or any of their properties,
in each case, that is material to the operations of the Company and its Subsidiaries.


 


(g)          Consents
and Approvals. No consent, approval, authorization, order, registration, notice, filing, recording or qualification of or with
any court or governmental agency or body having jurisdiction over the Company or any of its Subsidiaries or any of their properties
is required for the execution and delivery by the Company of the Transaction Agreements, the performance by the Company of its
obligations hereunder and thereunder and the consummation of the transactions contemplated hereby and thereby, including the distribution
of the Rights, the sale, issuance and delivery of Offered Shares upon exercise of the Rights and the Investor Shares to the Investor
hereunder, except (i) the registration under the Securities Act of 1933, as amended (the “Securities Act”),
of the issuance of the Rights and the Offered Shares pursuant to the exercise of Rights, and (ii) such consents, approvals, authorizations,
registrations or qualifications as may be required under state securities or Blue Sky laws in connection with the purchase of the
Investor Shares by the Investor or the distribution of the Rights and the sale of Shares to holders of Rights.


 




    	 	8	 



     

    

 


 


(h)          Arm’s
Length. The Company acknowledges and agrees that the Investor is acting solely in the capacity of an arm’s length contractual
counterparty to the Company with respect to the transactions contemplated hereby (including in connection with determining the
terms of the Rights Offering) and not as a financial advisor or a fiduciary to, or an agent of, the Company or any other person
or entity. Additionally, the Investor is not advising the Company or any other person or entity as to any legal, tax, investment,
accounting or regulatory matters in any jurisdiction. The Company shall consult with its own advisors concerning such matters and
shall be responsible for making its own independent investigation and appraisal of the transactions contemplated hereby, and the
Investor shall not have any responsibility or liability to the Company, its Affiliates, or their respective shareholders, directors,
officers, employees, advisors or other representatives with respect thereto. Any review by the Investor of the Company, the transactions
contemplated hereby or other matters relating to such transactions will be performed solely for the benefit of the Investor and
shall not be on behalf of the Company, its Affiliates, or their respective shareholders, directors, officers, employees, advisors
or other representatives and shall not affect any of the representations or warranties contained herein or the remedies of the
Investor with respect thereto.


 


(i)          Company
SEC Documents. Since January 1, 2014, the Company has filed or submitted all required reports, schedules, forms, statements
and other documents (including exhibits and all other information incorporated therein) (“Company SEC Documents”)
with the Securities and Exchange Commission (the “Commission”). As of their respective dates, each of the Company
SEC Documents complied in all material respects with the requirements of the Securities Act or the Exchange Act and the rules and
regulations of the Commission promulgated thereunder applicable to such Company SEC Documents. The Company has filed with the Commission
all “material contracts” (as such term is defined in Item 601(b)(10) of Regulation S-K under the Exchange Act) that
are required to be filed as exhibits to the Company SEC Documents and there are no contracts or other documents that are required
under the Exchange Act to be described in the Company SEC Documents that are not so described. No Company SEC Document filed after
January 1, 2014, when filed, or, in the case of any Company SEC Document amended or superseded prior to the date of this Agreement,
then on the date of such amending or superseding filing, contained any untrue statement of a material fact or omitted to state
a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading. Any Company SEC Documents filed with the Commission prior to the Closing Date, when filed,
will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
to make the statements therein, in light of the circumstances under which they are made, not misleading.


 




    	 	9	 



     

    

 


 


(j)          Financial
Statements. The financial statements and the related notes of the Company and its consolidated Subsidiaries included or incorporated
by reference in the Company SEC Documents, and to be included or incorporated by reference in the Rights Offering Registration
Statement, the Rights Offering Prospectus and the Shelf Registration Statement, comply or will comply, as the case may be, in all
material respects with the applicable requirements of the Securities Act and the Exchange Act, as applicable, and present fairly
in all material respects the financial position, results of operations and cash flows of the Company and its Subsidiaries as of
the dates indicated and for the periods specified, subject, in the case of the unaudited financial statements, to absence of disclosure
normally made in footnotes and to customary year-end adjustments which shall not be material; such financial statements have been
prepared in conformity with U.S. generally accepting accounting principles (“GAAP”) applied on a consistent
basis throughout the periods covered thereby, and the supporting schedules included or incorporated by reference in the Company
SEC Documents, and to be included or incorporated by reference in the Rights Offering Registration Statement, the Rights Offering
Prospectus and the Shelf Registration Statement, present fairly the information required to be stated therein in all material respects;
and the other financial information included or incorporated by reference in the Company SEC Documents, and to be included or incorporated
by reference in the Rights Offering Registration Statement, the Rights Offering Prospectus and the Shelf Registration Statement,
has been or will be derived from the accounting records of the Company and its Subsidiaries and presents fairly or will present
fairly the information shown thereby in all material respects.


 


(k)          Rights
Offering Registration Statement, Rights Offering Prospectus and the Shelf Registration Statement. The Rights Offering Registration
Statement or any post-effective amendment thereto, and the Shelf Registration Statement, will comply in all material respects with
the Securities Act, and will not contain any untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein not misleading; and as of the applicable filing date of the Rights Offering
Prospectus and any amendment or supplement thereto and as of the Closing Date, the Rights Offering Prospectus will not contain
any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the
statements therein, in the light of the circumstances under which they were made, not misleading. On the date the Rights are distributed
to Eligible Holders and the Expiration Date, the Investment Decision Package will not contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of
the circumstances under which they were made, not misleading. Each Issuer Free Writing Prospectus, at the time of use thereof,
when considered together with the other components of the Investment Decision Package, will not contain an untrue statement of
a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in
the light of the circumstances under which they were made, not misleading. Each Preliminary Rights Offering Prospectus, at the
time of filing thereof, will comply in all material respects with the Securities Act and will not contain any untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading. Notwithstanding the foregoing, the Company makes
no representation and warranty with respect to any statements or omissions made in reliance on and in conformity with information
relating to the Investor furnished to the Company in writing by the Investor expressly for use in the Rights Offering Registration
Statement and the Rights Offering Prospectus and any amendment or supplement thereto.


 




    	 	10	 



     

    

 


For the purposes of this Agreement, (i)
the term “Rights Offering Registration Statement” means the Registration Statement on Form S-3 to be filed with
the Commission relating to the Rights Offering, including all exhibits thereto and any post-effective amendment thereto that becomes
effective; (ii) the term “Rights Offering Prospectus” means the final prospectus contained in the Rights Offering
Registration Statement at the Securities Act Effective Date (including information, if any, omitted pursuant to Rule 430A and subsequently
provided pursuant to Rule 424(b) under the Securities Act), and any amended form of such prospectus provided under Rule 424(b)
under the Securities Act or contained in a post-effective amendment to the Rights Offering Registration Statement; (iii) the term
“Investment Decision Package” means the Rights Offering Prospectus, together with any Issuer Free Writing Prospectus
used by the Company to offer the Shares to Eligible Holders pursuant to the Rights Offering, (iv) the term “Issuer Free
Writing Prospectus” means each “issuer free writing prospectus” (as defined in Rule 433 of the rules promulgated
under the Securities Act) prepared by or on behalf of the Company or used or referred to by the Company in connection with the
Rights Offering, and (v) the term “Preliminary Rights Offering Prospectus” means each prospectus included in
the Rights Offering Registration Statement (and any amendments thereto) before it becomes effective, any prospectus filed with
the Commission pursuant to Rule 424(a) under the Securities Act and the prospectus included in the Rights Offering Registration
Statement, at the time of effectiveness that omits information permitted to be excluded under Rule 430A under the Securities Act.


 


(l)          Absence
of Certain Changes. Since January 1, 2014, other than as disclosed in the Company SEC Documents prior to the date hereof, and
except for actions to be taken pursuant to the Transaction Agreements:


 


(i)          there
has not been any change in the capital stock from that set forth in Section 3(d) or in long-term debt of the Company or
any of its Subsidiaries, or any dividend or distribution of any kind declared, set aside for payment, paid or made by the Company
on any class of capital stock;


 


(ii)         the
Company has not incurred any material liability other than in the ordinary course of business; and


 


(iii)        no
event, fact or circumstance has occurred which has had or would reasonably be expected to have, individually or in the aggregate,
a Material Adverse Effect.


 


(m)          No
Violation or Default; Compliance with Laws. Neither the Company nor any of its Subsidiaries is in violation of its charter
or by-laws or similar organizational documents. Neither the Company nor any of its Subsidiaries is in material default, and no
event has occurred that, with notice or lapse of time or both, would constitute such a material default, in the due performance
or observance of any material term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or
other material agreement or instrument to which the Company or any of its Subsidiaries is a party or by which the Company or any
of its Subsidiaries is bound or to which any of the property or assets of the Company or any of its Subsidiaries is subject. Neither
the Company nor any of its Subsidiaries is, or has been at any time since January 1, 2014, in violation of any law or statute or
any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority that is material to
the operations of the Company and its Subsidiaries.


 




    	 	11	 



     

    

 


 


(n)          Legal
Proceedings. Except as described in the Company SEC Documents filed prior to the date hereof, there are no (i) actions, suits
or proceedings (“Actions”) pending against the Company or any of its Subsidiaries, or (ii) pending or threatened
investigations or audits by any governmental or regulatory authority, in each case that are that required under the Exchange Act
to be described in the Company SEC Documents or the Rights Offering Registration Statement or that if determined adversely to the
Company or any of its Subsidiaries, would be material to the operations of the Company and its Subsidiaries taken together as a
whole. Except as described in the Company SEC Documents filed prior to the date hereof, there are no outstanding orders, writs,
injunctions, decrees, stipulations, determinations or awards entered by or with any governmental entity or addressed to or naming
as a party the Company or any Subsidiary, and there are no unsatisfied judgments, penalties or awards against, relating to or affecting
the Company or any Subsidiary.


 


(o)          Employee
Benefit Matters.


 


(i)          The
Company has made available to the Investor a true, correct and complete copy of each welfare, benefit, retirement, employment,
compensation, incentive, stock option, restricted stock, stock appreciation right, phantom equity, deferred compensation, change
in control, severance, vacation, paid time off, fringe-benefit and other similar agreement, plan, policy, program and other arrangement
(and any amendments thereto), whether or not reduced to writing, in effect and covering one or more directors, officers or employees,
former directors, officers or employees and/or the beneficiaries or dependents of any such director, officer or employee or former
director, officer or employee of the Company or any Subsidiary, that is maintained, sponsored, contributed to, or required to be
contributed to by Company or any Subsidiary, or under which the Company or any Subsidiary has or may have any liability for premiums
or benefits (each, a “Benefit Plan”).


 


(ii)         Except
as disclosed to the Investor prior to the date hereof or specifically disclosed in the Company SEC Documents filed prior to the
date hereof, no Benefit Plan provides benefits or coverage in the nature of health, life or disability insurance following retirement
or other termination of employment or service with the Company, as a director, officer or employee of the Company.


 


(iii)        Except
as disclosed to the Investor prior to the date hereof or specifically disclosed in the Company SEC Documents filed prior to the
date hereof, there have not been, nor are there presently, any benefits or other amounts paid or payable to any current or former
director of the Company or any affiliate thereof.


 


(iv)        There
is no pending or threatened Action relating to a Benefit Plan, and no Benefit Plan has within the three (3) years prior to the
date hereof been the subject of an examination or audit by a governmental entity or is the subject of an application or filing
under, or is a participant in, an amnesty, voluntary compliance, self-correction or similar program sponsored by any governmental
entity.


 




    	 	12	 



     

    

 


 


(p)          No
Broker’s Fees. Neither the Company nor any of its Subsidiaries is a party to any contract, agreement or understanding
with any person (other than this Agreement) that would give rise to any brokerage commission, finder’s fee or like payment
in connection with the Rights Offering or the sale of the Investor Shares.


 


(q)          No
Registration Rights. Except as provided for pursuant to this Agreement, the Registration Rights Agreement and the Investment
Agreement entered into between the Company and Third Avenue Trust, on behalf of Third Avenue Real Estate Value Fund, dated as of
the date hereof, and except as disclosed to the Investor prior to the date hereof or specifically disclosed in the Company SEC
Documents filed prior to the date hereof, no person has the right to require the Company or any of its Subsidiaries to register
any securities for sale under the Securities Act.


 


(r)          Charter;
Take-Over Statutes. The Board of Directors and Audit Committee of the Board of Directors have each taken (or shall have taken
by the Closing) all necessary action to waive and/or approve the Transaction Agreements and the consummation of the transactions
contemplated hereby and thereby and for purposes of Article Fourteenth of the Company’s certificate of incorporation. The
holder of the Series A preferred stock and the Series A Director (as defined in the Company’s certificate of incorporation)
have each taken (or shall have taken by the Closing) all necessary action to approve the Transaction Agreements and the consummation
of the transactions contemplated hereby and thereby for purposes of the Company’s certificate of incorporation. No “fair
price,” “moratorium,” “control share acquisition”, “business combination” or other similar
anti-takeover statute or regulation (a “Takeover Statute”) is applicable to the Company, the Common Stock, the
sale and issuance of the Offered Shares and the Investor Shares or the other transactions contemplated by the Transaction Agreements.


 


(s)          Transactions
with Affiliates. Except as disclosed to the Investor in writing prior to the date hereof or specifically disclosed in the Company
SEC Documents, (i) there are no contracts, agreements, arrangements, understandings (in each case whether written or oral), liabilities
or obligations between the Company or any Subsidiary, on the one hand, and any current or former officer or director of the Company
or any Subsidiary (or any of their respective affiliates or immediate family members), on the other hand, (ii) neither the Company
nor any Subsidiary provides or causes to be provided any assets, services or facilities to any person described in clause (i) of
this Section 3(s), (iii) no person described in clause (i) of this Section 3(s) provides or causes to be provided
any assets, services or facilities to the Company or any Subsidiary, or derives any benefit from any assets, services or facilities
of the Company or any Subsidiary (other than as explicitly contemplated by the terms of such person’s employment by the Company
or any Subsidiary).


 


(t)          No
Material Misstatements. No representation or warranty made by the Company in this Agreement or any other Transaction Agreement
contains an untrue statement of a material fact or omits to state a material fact required to be stated herein or therein or necessary
to make the statements contained herein or therein not misleading.


 




    	 	13	 



     

    

 


 


(u)          No
Solicitation. Neither the Company nor any agent acting on its behalf has solicited or will solicit any offers to sell or has
offered to sell or will offer to sell all or any part of the Investor Shares to any Person or Persons so as to bring the sale of
such Investor Shares to the Investor within the registration provisions of the Securities Act or any state securities laws.


 


4.          Representations
and Warranties of the Investor. The Investor represents and warrants to, and agrees with the Company, as set forth below. Except
for representations, warranties and agreements that are expressly limited as to their date, each representation, warranty and agreement
is made as of the date hereof and as of the Closing Date after giving effect to the transactions contemplated hereby:


 


(a)          Authority.
The Investor has the requisite power and authority to enter into, execute and deliver each Transaction Agreement to which it will
be a party as contemplated by this Agreement and to perform its obligations hereunder and thereunder and consummate the transactions
contemplated hereby and thereby, including the subscription for the Investor Shares. The Investor has taken all necessary action
required for the due authorization, execution, delivery and performance by it of this Agreement, including the subscription for
the Investor Shares.


 


(b)          Execution
and Delivery; Enforceability. Each Transaction Agreement to which the Investor is a party as contemplated by this Agreement
has been, or prior to its execution and delivery at the Closing will be, duly and validly executed and delivered by the Investor,
and each such document constitutes, or will constitute, the valid and binding obligation of the Investor, enforceable against the
Investor in accordance with its terms subject to (i) bankruptcy, insolvency, moratorium and other similar laws now or hereafter
in effect relating to or affecting creditors’ rights generally, and (ii) general principles of equity (regardless of whether
considered in a proceeding at law or in equity).


 


(c)          No
Registration. The Investor understands that the Investor Shares have not been registered under the Securities Act by reason
of a specific exemption from the registration provisions of the Securities Act, the availability of which depends upon, among other
things, the bona fide nature of the investment intent and the accuracy of the Investor’s representations as expressed herein
or otherwise made pursuant hereto.


 


(d)          Investment
Intent. The Investor is acquiring the Investor Shares for investment for its own account, not as a nominee or agent, and not
with the view to, or for resale in connection with, any distribution thereof not in compliance with applicable securities laws,
and the Investor has no present intention of selling, granting any participation in, or otherwise distributing the same, except
in compliance with applicable securities laws.


 


(e)          Securities
Laws Compliance. The Investor Shares will not be offered for sale, sold or otherwise transferred by the Investor except pursuant
to a registration statement or in a transaction exempt from, or not subject to, registration under the Securities Act and any applicable
state securities laws.


 




    	 	14	 



     

    

 


 


(f)          Sophistication.
The Investor has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and
risks of its investment in the Investor Shares being acquired hereunder. The Investor is a “qualified institutional buyer”
within the meaning of Rule 144A under the Securities Act or an “accredited investor” within the meaning of Rule 501
of Regulation D under the Securities Act. The Investor understands and is able to bear any economic risks associated with such
investment (including, without limitation, the necessity of holding the Investor Shares for an indefinite period of time). Without
derogating from or limiting the representations and warranties of the Company, the Investor acknowledges that it has been afforded
the opportunity to ask questions and receive answers concerning the Company and to obtain additional information that it has requested
to verify the information contained herein.


 


(g)          Legended
Securities. The Investor understands and acknowledges that upon the original issuance thereof, and until such time as the same
is no longer required under any applicable requirements of the Securities Act or applicable state securities laws, the Investor
Shares shall be represented by a certificate bearing the following legend (the “Securities Act Legend”):


 


“THE SECURITIES REPRESENTED
HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”).
THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES FOR THE BENEFIT OF THE CORPORATION THAT SUCH SECURITIES MAY BE OFFERED,
SOLD OR OTHERWISE TRANSFERRED ONLY PURSUANT TO (1) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR (2) AN EXEMPTION
FROM REGISTRATION UNDER THE SECURITIES ACT.”


 


The Investor further
understands and acknowledges that upon the original issuance thereof, and until such time as the Board of Directors of the Company
deems it no longer necessary or advisable under the Company’s charter or otherwise, the certificate representing the Investor
Shares shall also bear the following legend (the “NOL Legend”):


 


“THE
CERTIFICATE OF INCORPORATION, AS AMENDED (THE “CERTIFICATE OF INCORPORATION”), OF THE CORPORATION CONTAINS RESTRICTIONS
PROHIBITING THE TRANSFER (AS DEFINED IN THE CERTIFICATE OF INCORPORATION) OF ANY STOCK OF THE CORPORATION (INCLUDING THE CREATION
OR GRANT OF CERTAIN OPTIONS) WITHOUT THE PRIOR AUTHORIZATION OF THE BOARD OF DIRECTORS OF THE CORPORATION (THE “BOARD OF
DIRECTORS”) IF SUCH TRANSFER AFFECTS THE PERCENTAGE OF STOCK OF THE CORPORATION (WITHIN THE MEANING OF SECTION 382 OF THE
INTERNAL REVENUE CODE OF 1986, AS AMENDED (THE “CODE”) AND THE TREASURY REGULATIONS PROMULGATED THEREUNDER) THAT IS
TREATED AS OWNED BY A HOLDER OF 4.75% OR MORE OF THE OUTSTANDING STOCK, AS DETERMINED UNDER THE CODE AND SUCH TREASURY REGULATIONS
(A “SUBSTANTIAL STOCKHOLDER”). IF THE TRANSFER RESTRICTIONS ARE VIOLATED, THEN THE TRANSFER WILL BE VOID AB INITIO
AND THE PURPORTED TRANSFEREE OF THE STOCK WILL BE REQUIRED TO TRANSFER EXCESS SECURITIES TO THE CORPORATION’S AGENT. IN THE
EVENT OF A TRANSFER WHICH DOES NOT INVOLVE SECURITIES OF THE CORPORATION WITHIN THE MEANING OF THE DELAWARE GENERAL CORPORATION
LAW (“INDIRECT SECURITIES”) BUT WHICH WOULD VIOLATE THE TRANSFER RESTRICTIONS, THE PURPORTED TRANSFEREE (OR THE RECORD
OWNER) OF THE INDIRECT SECURITIES WILL BE REQUIRED TO TRANSFER SUFFICIENT INDIRECT SECURITIES PURSUANT TO THE TERMS PROVIDED FOR
IN THE CERTIFICATE OF INCORPORATION TO CAUSE THE SUBSTANTIAL STOCKHOLDER TO NO LONGER BE IN VIOLATION OF THE TRANSFER RESTRICTIONS.
THE CORPORATION WILL FURNISH WITHOUT CHARGE TO THE HOLDER OF RECORD OF THIS CERTIFICATE A COPY OF THE RELEVANT GOVERNING DOCUMENTS,
CONTAINING THE ABOVE-REFERENCED TRANSFER RESTRICTIONS, UPON WRITTEN REQUEST TO THE CORPORATION AT ITS PRINCIPAL PLACE OF BUSINESS.”


 




    	 	15	 



     

    

 


The foregoing Securities
Act Legend shall be promptly removed from Investor Shares and the Company shall issue, or cause to be issued, to the Investor a
certificate for such Investor Shares without such legend or any other legend (other than the NOL Legend), or, if so requested by
the Investor, by electronic delivery at the applicable balance account at the Depository Trust Company (“DTC”),
if one of the following conditions is met: (a) such Investor Shares are eligible for resale pursuant to Rule 144 of the Securities
Act without regard to any volume limitations; (b) in connection with a sale, assignment or other transfer of such Investor Shares,
the Investor provides the Company with an opinion of counsel, in a generally acceptable form to the Company and its transfer agent,
to the effect that such sale, assignment or transfer of such Investor Shares may be made without registration under the applicable
requirements of the Securities Act and that the legend can be removed from the Investor Shares; or (c) the Investor Shares are
registered and sold pursuant to an effective registration statement for resale under the Securities Act (including pursuant to
the Shelf Registration Statement).


 


Any fees (with respect
to the transfer agent or otherwise) associated with the removal of such legend shall be borne by the Company. Following the effective
date of the Shelf Registration Statement, or at such time as a Securities Act Legend is no longer required for any Investor Shares,
the Company will use its commercially reasonable efforts to no later than three (3) trading days following the delivery by the
Investor to the Company or its transfer agent (with notice to the Company) of a legended certificate representing such Investor
Shares (endorsed or with stock powers attached and otherwise in form necessary to effect the reissuance and/or transfer), deliver
or cause to be delivered to the Investor a certificate representing such Investor Shares that is free from all restrictive and
other legends (other than the NOL Legend). The Company may not make any notation on its records or give instructions to the transfer
agent that enlarge the restrictions on transfer set forth in this Section 4(g). Certificates for Investor Shares subject
to legend removal hereunder may be transmitted by the transfer agent to such Investor by crediting the account of such Investor’s
prime broker with DTC as directed by such Investor.


 




    	 	16	 



     

    

 


 


(h)          No
Conflict. The execution and delivery by the Investor of each of the Transaction Agreements to which it is a party and the compliance
by the Investor with all of the provisions hereof and thereof and the consummation of the transactions contemplated herein and
therein (including the subscription for and purchase of the Investor Shares by the Investor) (i) will not conflict with, or result
in a breach or violation of, any of the terms or provisions of, or constitute a default under (with or without notice or lapse
of time, or both), or result, in the acceleration of, or the creation of any lien under, any indenture, mortgage, deed of trust,
loan agreement or other material agreement or instrument to which the Investor is a party or by which the Investor is bound or
to which any of the property or assets of the Investor is subject, (ii) will not result in any violation of the provisions of the
certificate of incorporation or bylaws or comparable organizational documents of the Investor and (iii) will not result in any
material violation of, or any termination or material impairment of any rights under, any law, rule or regulation, any license,
authorization, injunction, judgment, order, decree, rule or regulation of any court or governmental agency or body having jurisdiction
over the Investor or any of its properties, except in any such case described in subclause (i) for any conflict, breach, violation,
default, acceleration or lien which has not and would not reasonably be expected, individually or in the aggregate, to prohibit,
materially delay or materially and adversely impact the Investor’s performance of its obligations under this Agreement.


 


(i)          Consents
and Approvals. No consent, approval, authorization, order, registration, notice, filing, recording or qualification of or with
any court or governmental agency or body having jurisdiction over the Investor or any of its or his properties is required for
the execution and delivery by the Investor of the Transaction Agreements to which it is a party, performance by the Investor of
its obligations hereunder and thereunder and the consummation of the transactions contemplated hereby and thereby, except for any
consent, approval, authorization, order, registration or qualification which, if not made or obtained, has not and would not reasonably
be expected, individually or in the aggregate, to prohibit, materially delay or materially and adversely impact the Investor’s
performance of its or his obligations under this Agreement.


 


(j)          Arm’s
Length. The Investor acknowledges and agrees that the Company is acting solely in the capacity of an arm’s length contractual
counterparty to the Investor with respect to the transactions contemplated hereby (including in connection with determining the
terms of the Rights Offering) and not as a financial advisor or a fiduciary to or an agent of, the Investor. Additionally, without
derogating from or limiting the representations and warranties of the Company, the Investor is not relying on the Company for any
legal, tax, investment, accounting or regulatory matters in any jurisdiction. Without derogating from or limiting the representations
and warranties of the Company, the Investor shall consult with its own advisors concerning such matters and shall be responsible
for making its own independent investigation and appraisal of the transactions contemplated hereby.


 


(k)          Share
Ownership. As of the date hereof, based on the methodology for calculating shares beneficially owned pursuant to Rules 13d-3
and 16a-1 of the Exchange Act, the Investor beneficially owns 1,000,000 shares of Common Stock.


 




    	 	17	 



     

    

 


 


(l)          Information
Furnished. Information relating to the Investor furnished to the Company in writing by the Investor expressly for use in the
Rights Offering Registration Statement and Shelf Registration Statement will not contain an untrue statement of a material fact
or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading.


 


5.          Covenants
of the Company. Without derogating from the obligations of the Company set forth elsewhere in this Agreement, the Company agrees
with the Investor as set forth below.


 


(a)          Rights
Offering Registration Statement.


 


(i)          As
promptly as practicable following the date of this Agreement, the Company shall prepare and file a Rights Offering Registration
Statement.


 


(ii)         The
Rights Offering Registration Statement when filed with the Commission shall be substantially consistent in all material respects
with the last form of such document provided to the Investor and its counsel to review prior to the filing thereof. The Company
shall: (x) provide the Investor with a reasonable opportunity to review the Rights Offering Registration Statement prior to its
filing with the Commission and shall duly consider in good faith any comments of the Investor and its counsel; (y) advise the Investor
promptly of the time when the Rights Offering Registration Statement has been filed or when the Rights Offering Registration Statement
has become effective or any Rights Offering Prospectus or Rights Offering Prospectus supplement has been filed and shall furnish
the Investor with copies thereof; and (z) advise the Investor promptly after it receives notice of any comments or inquiries by
the Commission (and furnish the Investor with copies of any correspondence related thereto), of the issuance by the Commission
of any stop order or of any order preventing or suspending the use of the Rights Offering Registration Statement, of the initiation
or threatening of any proceeding for any such purpose, or of any request by the Commission for the amending or supplementing the
Rights Offering Registration Statement or for additional information, and in each such case, provide the Investor with a reasonable
opportunity to review any such comments, inquiries, request or other communication from the Commission and to review any amendment
or supplement to the Rights Offering Registration Statement before any filing with the Commission, and to duly consider in good
faith any comments consistent with this Agreement and any other reasonable comments of the Investor and its counsel and in the
event of the issuance of any stop order or of any order preventing or suspending the use of the Rights Offering Registration Statement
or suspending any such qualification, to use promptly its commercially reasonable efforts to obtain its withdrawal.


 


(iii)        The
Company shall use its commercially reasonable efforts to have the Rights Offering Registration Statement declared effective by
the Commission as promptly as practicable after such filing. The Company shall take all action as may be reasonably necessary or
advisable so that the Rights Offering and the issuance and sale of the Investor Shares and the other transactions contemplated
by this Agreement will be effected in accordance with the applicable provisions of the Securities Act and the Exchange Act and
any state or foreign securities or Blue Sky laws.


 




    	 	18	 



     

    

 


 


(iv)        If
at any time prior to the Expiration Time, any event occurs as a result of which the Investment Decision Package, as then amended
or supplemented, would include an untrue statement of a material fact or omit to state any material fact necessary in order to
make the statements therein, in the light of the circumstances under which they were made, not misleading, or if it shall be necessary
to amend or supplement the Investment Decision Package to comply with applicable law, the Company will promptly notify the Investor
of any such event and prepare an amendment or supplement to the Investor Decision Package that is reasonably acceptable in form
and substance to the Investor that will correct such statement or omission or effect such compliance.


 


(b)          Company
Expenses. The Company will pay all of its expenses associated with the Rights Offering, issuance of the Investor Shares, preparation,
negotiation and execution of all Transaction Agreements and the transactions contemplated hereby and thereby, including, without
limitation, filing and printing fees, fees and expenses of any subscription and information agents, its counsel and accounting
fees and expenses, costs associated with the Rights Offering Registration Statement, the Shelf Registration Statement and with
clearing the Shares offered thereby for sale under applicable state securities laws.


 


(c)          Commercially
Reasonable Efforts. The Company shall use its commercially reasonable efforts to take or cause to be taken all actions, and
do or cause to be done all things, reasonably necessary, proper or advisable on its part under this Agreement and applicable laws
to cooperate with the Investor and to consummate and make effective the transactions contemplated by this Agreement, including:


 


(i)          preparing
and filing as promptly as practicable all documentation to effect all necessary notices, reports and other filings and to obtain
as promptly as practicable all consents, registrations, approvals, permits and authorizations necessary or advisable to be obtained
from any third party or governmental entity;


 


(ii)         defending
any lawsuits or other actions or proceedings, whether judicial or administrative, challenging this Agreement or any other agreement
contemplated by this Agreement or the consummation of the transactions contemplated hereby and thereby, including seeking to have
any stay or temporary restraining order entered by any court or other governmental entity vacated or reversed; and


 


(iii)        executing,
delivering and filing, as applicable, any additional ancillary instruments or agreements reasonably necessary to consummate the
transactions contemplated by this Agreement and to fully carry out the purposes of this Agreement and the transactions contemplated
hereby and thereby.


 


(d)          Rule
144. The Company will use its commercially reasonable efforts to timely file all reports and other documents required to be
filed by it under the Securities Act and the Exchange Act and the rules and regulations adopted by the Commission thereunder (or,
if the Company is not required to file such reports, it will, upon the request of the Investor, make publicly available such information
as necessary to permit sales pursuant to Rule 144 of the Securities Act), and will use commercially reasonable efforts to take
such further action as the Investor may reasonably request, all to the extent required from time to time to enable the Investor
to sell Investor Shares without registration under the Securities Act within the limitation of the exemptions provided by Rule
144 of the Securities Act.


 




    	 	19	 



     

    

 


 


(e)          Registration
Rights Agreement. At or prior to the Closing, the Company shall enter into the Registration Rights Agreement with the Investor
pursuant to which the Company agrees to register all of the Shares held by the Investor and/or its Affiliates immediately following
the consummation of the transactions contemplated by this Agreement, including all Shares held by the Investor and/or its Affiliates
as of the date hereof.


 


6.          Additional
Covenants of the Investor. Without derogating from the obligations of the Investor set forth elsewhere in this Agreement, the
Investor agrees with the Company:


 


(a)          Information.
The Investor shall provide the Company with such information as the Company reasonably requests regarding the Investor for inclusion
in the Rights Offering Registration Statement and Shelf Registration Statement.


 


(b)          Cooperation.
The Investor shall cooperate with the Company in taking all action necessary to consummate the transactions contemplated by this
Agreement, including executing, delivering and filing, as applicable, any additional ancillary instruments or agreements necessary
to consummate the transactions contemplated by this Agreement and to fully carry out the purposes of this Agreement and the transactions
contemplated hereby and thereby.


 


7.          Conditions
to the Obligations of the Parties.


 


(a)          The
obligations of the Investor hereunder to consummate the transactions contemplated hereby shall be subject to the satisfaction prior
to the Closing Date of each of the following conditions (which may be waived in whole or in part by the Investor in its sole discretion):


 


(i)          Rights
Offering Registration Statement Effectiveness. The Rights Offering Registration Statement shall have been declared effective
by the Commission and shall continue to be effective and no stop order shall have been entered by the Commission with respect thereto.


 


(ii)         Rights
Offering. The Rights Offering shall have been completed by the Company in accordance with the terms and conditions set forth
in this Agreement and the Rights Offering Registration Statement.


 


(iii)        Purchase
or Satisfaction Notice. The Investor shall have timely received either a Purchase Notice from the Company on the Determination
Date, certifying the number of Unsubscribed Shares to be purchased pursuant to the Backstop Commitment, or a Satisfaction Notice.


 


(iv)        Consents.
All other governmental and third party notifications, filings, consents, waivers and approvals required for the consummation of
the transactions contemplated by this Agreement shall have been made or received.


 




    	 	20	 



     

    

 


 


(v)         No
Legal Impediment to Issuance. No statute, rule, regulation or order shall have been enacted, adopted or issued by any federal,
state or foreign governmental or regulatory authority, and no judgment, injunction, decree or order of any federal, state or foreign
court shall have been issued that prohibits the issuance of the Offered Shares in the Rights Offering, the issuance of the Investor
Shares to the Investor or the consummation of the transactions contemplated by this Agreement.


 


(vi)        Good
Standing. The Investor shall have received on and as of the Closing Date satisfactory evidence of the good standing of the
Company in the State of Delaware, in writing or any standard form of telecommunication from the appropriate governmental authorities
of such jurisdiction.


 


(vii)       Representations
and Warranties. The representations and warranties of Company contained in this Agreement shall be true and correct in all
material respects (disregarding all qualifications and exceptions contained therein relating to materiality, Material Adverse Effect
or similar qualifications) other than representations and warranties contained in Section 3(e), which shall be true and
correct in all respects.


 


(viii)      Covenants.
The Company shall have performed and complied in all material respects with all of its respective covenants and agreements contained
in this Agreement and in any other document delivered pursuant to this Agreement (including in any Transaction Agreement) through
the Closing Date.


 


(ix)         Certificate.
The Company shall have furnished to the Investor a certificate, dated the Closing Date, of an officer of the Company, on behalf
of the Company, confirming the matters set forth in subsections (vii) and (viii).


 


(x)          Fees
and Expenses. The Company shall have paid all fees, costs and expenses payable to the Investor pursuant to Section 2.


 


(xi)         No
Material Adverse Effect. Since the date of this Agreement, there shall not have occurred any changes or events that, individually
or in the aggregate would reasonably be expected to result in a Material Adverse Effect.


 


(xii)        No
Market Adverse Event. There shall not have occurred (i) a material adverse change in the financial markets in the United States,
any outbreak of hostilities or escalation thereof or other calamity or crisis or any change or development involving a prospective
change in national or international political, financial or economic conditions, or (ii) a suspension or material limitation on
trading, or minimum or maximum prices for trading have been fixed, or maximum ranges for prices have been required, by any securities
exchange or by such system or by order of the Commission, the New York Stock Exchange or any other governmental authority, or (iii)
a material disruption in commercial banking or securities settlement or clearance services in the United States, or (iv) a declaration
of a banking moratorium by either Federal or New York authorities.


 




    	 	21	 



     

    

 


 


(b)          The
obligation of the Company to consummate the Rights Offering and to issue and sell the Investor Shares are subject to the following
conditions (which may be waived in whole or in part by the Company in its sole discretion):


 


(i)          No
Legal Impediment to Issuance. No statute, rule, regulation or order shall have been enacted, adopted or issued by any federal,
state or foreign governmental or regulatory authority, and no judgment, injunction, decree or order of any federal, state or foreign
court shall have been issued that prohibits the issuance of the Offered Shares in the Rights Offering, the issuance of the Investor
Shares to the Investor or the consummation of the transactions contemplated by this Agreement.


 


(ii)         Representations
and Warranties. The representations and warranties of the Investor, each Affiliated Purchaser contained in this Agreement or
pursuant to Section 1(h) shall be true and correct in all material respects (disregarding all qualifications and exceptions
contained therein relating to materiality or similar qualifications).


 


(iii)        Covenants.
The Investor shall have performed and complied in all material respects with all of its covenants and agreements contained in this
Agreement and in any other document delivered pursuant to this Agreement (including in any Transaction Agreement) through the Closing
Date.


 


(iv)        Rights
Offering. The Rights Offering shall have been completed by the Company in accordance with the terms and conditions set forth
in this Agreement and the Rights Offering Registration Statement.


 


(v)         Rights
Offering Registration Statement Effectiveness. The Rights Offering Registration Statement shall have been declared effective
by the Commission and shall continue to be effective and no stop order shall have been entered by the Commission with respect thereto.


 


(vi)        No
Market Adverse Event. There shall not have occurred (i) a material adverse change in the financial markets in the United States,
any outbreak of hostilities or escalation thereof or other calamity or crisis or any change or development involving a prospective
change in national or international political, financial or economic conditions, or (ii) a suspension or material limitation on
trading, or minimum or maximum prices for trading have been fixed, or maximum ranges for prices have been required, by any securities
exchange or by such system or by order of the Commission, the New York Stock Exchange or any other governmental authority, or (iii)
a material disruption in commercial banking or securities settlement or clearance services in the United States, or (iv) a declaration
of a banking moratorium by either Federal or New York authorities.


 




    	 	22	 



     

    

 


 


8.          Indemnification
and Contribution.


 


(a)          Whether
or not the Rights Offering, the issuance of the Investor Shares to the Investor or the other transactions contemplated hereby are
consummated or this Agreement is terminated, the Company (in such capacity, the “Indemnifying Party”) shall
indemnify and hold harmless the Investor and each Affiliated Purchaser, their respective Affiliates and their respective officers,
directors, members, managers, partners, employees, agents, advisors and controlling persons (each, an “Indemnified Person”)
from and against any and all losses, claims, damages, liabilities, amounts paid in settlement and reasonable expenses, joint or
several (“Losses”) incurred by such Indemnified Person or to which any such Indemnified Person may become subject
arising out of or in connection with any claim, challenge, litigation, investigation or proceeding (“Proceedings”)
arising out of or relating to the Rights Offering, this Agreement or the other Transaction Agreements, the Rights Offering Registration
Statement, any Preliminary Rights Offering Prospectus, the Rights Offering Prospectus, any Issuer Free Writing Prospectus, the
Investment Decision Package, any amendment or supplement thereto or the transactions contemplated by any of the foregoing and shall
reimburse such Indemnified Persons for any reasonable legal fees and expenses or other out-of-pocket expenses incurred in connection
with investigating, responding to or defending any of the foregoing; provided that the foregoing indemnification will not
apply to Losses to the extent that they resulted from (i) gross negligence or willful misconduct on the part of such Indemnified
Person or (ii) statements or omissions in the Rights Offering Registration Statement, any Preliminary Rights Offering Prospectus,
the Rights Offering Prospectus, any Issuer Free Writing Prospectus or any amendment or supplement thereto made in reliance upon
or in conformity with information relating to such Indemnified Person furnished to the Company in writing by or on behalf of such
Indemnified Person expressly for use in the Rights Offering Registration Statement, any Rights Offering Preliminary Prospectus,
the Rights Offering Prospectus, any Issuer Free Writing Prospectus or any amendment or supplement thereto. If for any reason the
foregoing indemnification is unavailable to any Indemnified Person (except as set forth in the proviso to the immediately preceding
section) or insufficient to hold it harmless, then the Indemnifying Party shall contribute to the amount paid or payable by such
Indemnified Person as a result of such Losses in such proportion as is appropriate to reflect not only the relative benefits received
by the Indemnifying Party on the one hand and such Indemnified Person on the other hand but also the relative fault of the Indemnifying
Party on the one hand and such Indemnified Person on the other hand as well as any relevant equitable considerations.


 


(b)          Promptly
after receipt by an Indemnified Person of notice of the commencement of any Proceedings with respect to which the Indemnified Person
may be entitled to indemnification hereunder, such Indemnified Person will, if a claim is to be made hereunder against the Indemnifying
Party in respect thereof, notify the Indemnifying Party in writing of the commencement thereof; provided that the omission
so to notify the Indemnifying Party will not relieve the Indemnifying Party from any liability that it may have hereunder except
to the extent it has been materially prejudiced by such failure. In case any such Proceedings are brought against any Indemnified
Person and it notifies the Indemnifying Party of the commencement thereof, the Indemnifying Party will be entitled to participate
therein, and, to the extent that it may elect by written notice delivered to such Indemnified Person, to assume the defense thereof,
with counsel reasonably satisfactory to such Indemnified Person; provided that if the defendants in any such Proceedings
include both such Indemnified Person and the Indemnifying Party and such Indemnified Person shall have concluded that there may
be legal defenses available to it that are different from or additional to those available to the Indemnifying Party, such Indemnified
Person shall have the right to select separate counsel, which selection shall be subject to the reasonable approval of the Indemnifying
Party (it being understood and agreed that Skadden, Arps, Slate, Meagher & Flom LLP is approved), to assert such legal defenses
and to otherwise participate in the defense of such Proceedings on behalf of such Indemnified Person. Upon receipt of notice from
the Indemnifying Party to such Indemnified Person of its election so to assume the defense of such Proceedings and approval by
such Indemnified Person of counsel, the Indemnifying Party shall not be liable to such Indemnified Person for expenses incurred
by such Indemnified Person thereafter in connection with the defense thereof (other than reasonable costs of investigation) unless
(i) such Indemnified Person shall have employed separate counsel in connection with the assertion of legal defenses in accordance
with the proviso to the preceding sentence (it being understood, however, that the Indemnifying Party shall not be liable for the
expenses of more than one firm of counsel, plus local counsel, in any jurisdiction representing the Indemnified Person), (ii) the
Indemnifying Party shall not have employed counsel reasonably satisfactory to such Indemnified Person to represent such Indemnified
Person within a reasonable time after notice of commencement of the Proceedings or (iii) the Indemnifying Party shall have authorized
in writing the employment of counsel for such Indemnified Person.


 




    	 	23	 



     

    

 


 


(c)          The
Indemnifying Party shall not be liable for any settlement of any Proceedings effected without its written consent (which consent
shall not be unreasonably withheld, conditioned or delayed). If any settlement of any Proceeding is consummated with the written
consent of the Indemnifying Party or if there is a final judgment for the plaintiff in any such Proceedings, the Indemnifying Party
agrees to indemnify and hold harmless each Indemnified Person from and against any and all Losses by reason of such settlement
or judgment in accordance with, and subject to the limitations of, the provisions of this Section 8. The Indemnifying Party
shall not, without the prior written consent of an Indemnified Person (which consent shall not be unreasonably withheld, conditioned
or delayed), effect any settlement of any pending or threatened Proceedings in respect of which indemnity has been sought hereunder
by such Indemnified Person unless (i) such settlement includes an unconditional release of such Indemnified Person in form and
substance satisfactory to such Indemnified Person from all liability on the claims that are the subject matter of such Proceedings
and (ii) such settlement does not include any statement as to or any admission of fault, culpability or a failure to act by or
on behalf of any Indemnified Person.


 


(d)          Given
that an Indemnified Person may be entitled to indemnification (a “Jointly Indemnifiable Claim”) from both the
Company, pursuant to this Agreement, and from any other Person, whether pursuant to applicable law, any indemnification agreement,
the organizational documents of such Person or otherwise (the “Indemnitee-Related Entities”), the Company acknowledges
and agrees that the Company shall be fully and primarily responsible for the payment to the Indemnified Person in respect of indemnification
and advancement of expenses in connection with any such Jointly Indemnifiable Claim, pursuant to and in accordance with the terms
of this Agreement, irrespective of any right of recovery the Indemnified Person may have from the Indemnitee-Related Entities.
Under no circumstance shall the Company be entitled to any right of subrogation or contribution by the Indemnitee-Related Entities
and no right of recovery the Indemnified Person may have from the Indemnitee-Related Entities shall reduce or otherwise alter the
rights of the Indemnified Person or the obligations of the Company hereunder. In the event that any of the Indemnitee-Related Entities
shall make any payment to the Indemnified Person in respect of indemnification or advancement of expenses with respect to any Jointly
Indemnifiable Claim, the Indemnitee-Related Entity making such payment shall be subrogated to the extent of such payment to all
of the rights of recovery of the Indemnified Person against the Company, and the Indemnified Person shall execute all papers reasonably
required and shall do all things that may be reasonably necessary to secure such rights, including the execution of such documents
as may be necessary to enable the Indemnitee-Related Entities effectively to bring suit to enforce such rights. Each of the Indemnitee-Related
Entities shall be third-party beneficiaries with respect to this Section 8(d), entitled to enforce this Section 8(d)
against the Company as though each such Indemnitee-Related Entity were a party to this Agreement.


 




    	 	24	 



     

    

 


 


9.          Survival
of Representations and Warranties. The representations and warranties made in this Agreement will survive the execution and
delivery of this Agreement and the consummation of the transactions contemplated hereby notwithstanding any investigation at any
time made by or on behalf of any party hereto until the date that is one year after the Closing Date and the covenants shall survive
in accordance with their specific terms; provided, however, the representations and warrants contained in Sections 3(b),
(c), (d), (e) and (g) and Sections 4(a), (b) and (i) shall survive indefinitely.


 


10.         Termination.
This Agreement may be terminated and the transactions contemplated hereby may be abandoned prior to the Closing Date:


 


(a)          by
mutual written consent of the Company and the Investor;


 


(b)          by
the Investor, with written notice to the Company:


 


(i)          if
there has been a breach of any covenant or a breach of any representation or warranty of the Company, which breach would cause
the failure of any condition precedent set forth in Section 7(a)(vii) or (viii) or upon the occurrence of any event
which results in a failure to satisfy any of the other conditions set forth in Section 7(a), provided, that any such
breach or failure is not capable of cure on or prior to February 12, 2016;


 


(ii)         if
the Rights Offering Registration Statement has not been declared effective by the Commission and the Rights Offering Commencement
Date has not occurred by February 12, 2016; or


 


(iii)        after
February 12, 2016; provided, that the Closing Date has not occurred by such date other than as a result of a breach by the
Investor of any of its obligations pursuant to this Agreement.


 


(c)          by
the Company, with written notice to the Investor:


 


(i)          if
there has been a breach of any covenant or a breach of any representation or warranty of the Investor, which breach would cause
the failure of any condition precedent set forth in Section 7(b)(ii) or (iii), or upon the occurrence of any event
which results in a failure to satisfy any of the other conditions set forth in Section 7(b), provided, that any such
breach or failure is not capable of cure on or prior to February 12, 2016;


 




    	 	25	 



     

    

 


 


(ii)         after
February 12, 2016; provided, that the Closing Date has not occurred by such date other than as a result of a breach by the
Company of any of its obligations pursuant to this Agreement.


 


(d)          If
this Agreement is terminated, provided that there was no breach of any representations, warranties or covenants in this Agreement
by the Investor at the date of termination which breach had materially delayed or materially adversely impacted the Investor’s
or the Company’s performance of their respective obligations under this Agreement, the Company shall pay the Investor any
Transaction Expenses due and payable hereunder that have not been paid theretofore. Payment of the amounts due under this Section
10(d) will be made no later than the close of business on the third (3rd) Business Day following the date of such termination
by wire transfer of immediately available funds in U.S. dollars to an account or accounts specified by the Investor to the Company.
The provision for the payment of the Transaction Expenses is an integral part of the transactions contemplated by this Agreement
and without this provision the Investor would not have entered into this Agreement.


 


(e)          Upon
termination under this Section 10, all rights and obligations of the parties under this Agreement shall terminate without
any liability of any party to any other party except that (x) nothing contained herein shall release any party hereto from liability
for any willful breach and (y) the covenants and agreements made by the parties herein in Section 2, and Section 8
and Sections 10 through 16 will survive indefinitely in accordance with their terms.


 


11.         Notices.
All notices and other communications in connection with this Agreement will be in writing and will be deemed given (and will be
deemed to have been duly given upon receipt) if delivered personally, sent via electronic transmission or facsimile (with confirmation),
mailed by registered or certified mail (return receipt requested) or delivered by an express courier (with confirmation) to the
parties at the following addresses (or at such other address for a party as will be specified by like notice):


 


(a)          If
to the Company:


 


Trinity Place Holdings Inc.

717 Fifth Avenue, Suite 1303

New York, New York 10022

Attention: Chief Executive Officer and Chief Financial Officer

Fax: (212) 235-2199


Email: matt.messinger@tphs.com and richard.pyontek@tphs.com


 


with a copy (which shall not constitute notice) to:


 


Kramer Levin Naftalis & Frankel LLP

1177 Avenue of the Americas

New York, NY 10036

Attention: John Bessonette

Fax: (212) 715-8044

Email: jbessonette@kramerlevin.com


 




    	 	26	 



     

    

 


 


(b)          If
to the Investor:


 


MFP Partners, L.P.

c/o MFP Investors LLC

667 Madison Avenue, 25th Floor


New York, NY 10065

Attention: Timothy E. Ladin

Fax: (212) 752-7265

Email: tladin@mfpllc.com


 


12.         Assignment;
Third Party Beneficiaries. Neither this Agreement nor any of the rights, interests or obligations under this Agreement may
be assigned by any of the parties (whether by operation of law or otherwise) without the prior written consent of the other party,
except to an Affiliated Purchaser pursuant to Section 1(h). Except as provided in Section 8 with respect to the Indemnified
Persons, this Agreement (including the documents and instruments referred to in this Agreement) is not intended to and does not
confer upon any person other than the parties hereto any rights or remedies under this Agreement. Any Indemnified Persons shall
be entitled to enforce and rely on the provisions listed in the immediately preceding sentence as if they were a party to this
Agreement.


 


13.         Prior
Negotiations; Entire Agreement. This Agreement (including the agreements attached as exhibits to and the documents and instruments
referred to in this Agreement) constitutes the entire agreement of the parties and supersedes all prior agreements, arrangements
or understandings, whether written or oral, between the parties with respect to the subject matter of this Agreement, except that
the parties hereto acknowledge that any confidentiality agreements heretofore executed among the parties will continue in full
force and effect.


 


14.         GOVERNING
LAW; VENUE. THIS AGREEMENT WILL BE GOVERNED AND CONSTRUED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF NEW YORK. THE
INVESTOR HEREBY IRREVOCABLY SUBMITS TO THE JURISDICTION OF, AND VENUE IN, THE UNITED STATES COURT FOR THE SOUTHERN DISTRICT OF
NEW YORK AND WAIVES ANY OBJECTION BASED ON FORUM NON CONVENIENS. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH
MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY
AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY
ARISING OUT OF OR RELATING TO THIS AGREEMENT, OR THE BREACH, TERMINATION OR VALIDITY OF THIS AGREEMENT, OR THE TRANSACTIONS CONTEMPLATED
BY THIS AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED,
EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B)
EACH SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (C) EACH SUCH PARTY MAKES THIS WAIVER VOLUNTARILY,
AND (D) EACH SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS
IN THIS SECTION 14.


 




    	 	27	 



     

    

 


 


15.         Counterparts.
This Agreement may be executed in counterparts, all of which will be considered one and the same agreement and will become effective
when counterparts have been signed by each of the parties and delivered to the other party (including via facsimile or other electronic
transmission), it being understood that each party need not sign the same counterpart.


 


16.         Waivers
and Amendments. This Agreement may be amended, modified, superseded, cancelled, renewed or extended, and the terms and conditions
of this Agreement may be waived, only by a written instrument signed by all the parties or, in the case of a waiver, by the party
waiving compliance. No delay on the part of any party in exercising any right, power or privilege pursuant to this Agreement will
operate as a waiver thereof, nor will any waiver on the part of any party of any right, power or privilege pursuant to this Agreement,
nor will any single or partial exercise of any right, power or privilege pursuant to this Agreement, preclude any other or further
exercise thereof or the exercise of any other right, power or privilege pursuant to this Agreement. The rights and remedies provided
pursuant to this Agreement are cumulative and are not exclusive of any rights or remedies which any party otherwise may have at
law or in equity.


 


17.         Adjustment
to Shares. If, prior to the Closing Date, the Company effects a reclassification, stock split (including a reverse stock split),
stock dividend or distribution, recapitalization, merger, issuer tender or exchange offer, or other similar transaction with respect
to any shares of its capital stock, references to the numbers of such shares and the prices therefore shall be equitably adjusted
to reflect such change and, as adjusted, shall, from and after the date of such event, be subject to further adjustment in accordance
herewith.


 


18.         Headings.
The headings in this Agreement are for reference purposes only and will not in any way affect the meaning or interpretation of
this Agreement.


 


19.         Publicity.
The Company and the Investor shall consult with each other prior to issuing any press releases (and provide each other a reasonable
opportunity to review and comment upon such release prior to its public issuance) or otherwise making public announcements with
respect to the transactions contemplated by this Agreement; provided, however, that in no event shall any such press release or
other public announcement name the Investor without its prior written consent. The Company shall consult with the Investor prior
to making any filings (and provide the Investor a reasonable opportunity to review and comment on such filings) with any third
party or any governmental entity (including any national securities exchange or interdealer quotation service) with respect to
the transactions contemplated by this Agreement, except as may be required by law or by the request of any governmental entity.
Subject to the Company’s foregoing obligations pursuant to this Section 19, nothing contained in this Section 19
shall be interpreted to preclude the Company from making any filing or disclosing any information in any filing, including with
the Commission, that the Company acting reasonably determines is necessary or advisable; provided, however, that, if such filing
names the Investor, the Company shall obtain the prior approval of the Investor and take into account any comments it may have
thereto unless, in the opinion of counsel to the Company, the filing is legally required to be made as proposed by the Company
without making changes to reflect such comments.


 






    	 	28	 



     

    

 


[Signature Page Follows]


 




    	 	29	 



     

    

 


IN WITNESS WHEREOF, the
parties hereto have caused this Agreement to be signed by their respective officers thereunto duly authorized, all as of the date
first written above.


 





	 	TRINITY PLACE HOLDINGS INC.
	 	 
	 	By:	/s/ Matthew Messinger
	 	Name:	Matthew Messinger
	 	Title:	President and Chief Executive Officer
	 	 
	 	MFP PARTNERS, L.P.
	 	By:	MFP Investors LLC,
	 	 	its General Partner
	 	 	 
	 	By:	/s/ Timothy Ladin
	 	Name:	Timothy Ladin
	 	Title:	General Counsel







 


[Signature Page to Investment Agreement]


 




    


     

    

 


EXHIBIT A


 


FORM OF REGISTRATION RIGHTS AGREEMENT


 


This REGISTRATION RIGHTS AGREEMENT (“Agreement”),
dated as of [__], 2015, is made by and between Trinity Place Holdings Inc., a Delaware corporation (the “Company”)
and MFP Partners, L.P., a Delaware limited partnership (the “Investor”).


 


WITNESSETH


 


WHEREAS, the Company
has entered into that certain Investment Agreement dated as of September 11, 2015 (the “Investment Agreement”)
between the Company and the Investor; and


 


WHEREAS, the Company
has conducted a rights offering (the “Rights Offering”) by distributing, at no charge, to each holder of record
(as of a record date determined by the Board (as defined below)) of shares of the Company’s common stock, par value $0.01
per share (the “Common Stock”), 0.248362 non-transferable rights (the “Rights”), for each
share of Common Stock held by such shareholder, to purchase shares of Common Stock which Rights, if exercised in full by each holder
of record as of such record date, would provide gross proceeds to the Company of Thirty Million Dollars ($30,000,000);


 


WHEREAS, in order to
facilitate the Rights Offering and pursuant to the Investment Agreement, (i) the Investor agreed to subscribe for and purchase,
at the Exercise Price, upon expiration of the Rights Offering, a specified portion (as specified in the Investment Agreement) of
the shares of Common Stock offered in the Rights Offering that were not purchased pursuant to the exercise of Rights in the Rights
Offering, and (iii) the Company agreed to issue and sell to the Investor additional shares of Common Stock at the Exercise Price
in an amount sufficient to enable the Investor to acquire an aggregate of 1,666,667 shares of Common Stock to the extent that the
Investor was not able to acquire such number of shares of Common Stock through its purchases in subsection (i) above, in each case,
upon the terms and subject to the conditions set forth in the Investment Agreement; and


 


WHEREAS, in consideration
of the Investor’s commitment to purchase certain shares of Common Stock pursuant to, upon the terms, and subject to the conditions
set forth in the Investment Agreement, the Company has agreed to provide registration rights to the Investor with respect to all
of the shares of Common Stock held by the Investor and/or its Affiliates (as defined below) immediately following the consummation
of the transactions contemplated by the Investment Agreement, including all shares of Common Stock held by the Investor and/or
its Affiliates as of the date of the Investment Agreement (the “Shares”).


 


NOW, THEREFORE, in consideration
of the mutual covenants and agreements set forth herein and for good and valuable consideration, the receipt of which is hereby
acknowledged, the parties agree as follows:


 




    	 	A-1	 



     

    

 


Article
I


 

Certain Definitions


 


For purposes of this
Agreement, the following terms shall have the following meanings:


 


(a)          The
term “Affiliate” means, with respect to any Person, any other Person directly or indirectly controlling, controlled
by, or under common control with, such Person; provided that, for the purposes of this definition, “control” (including,
with correlative meanings, the terms “controlled by” and “under common control with”), as used with respect
to any Person, shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management
and policies of such Person, whether through the ownership of voting securities, by contract or otherwise.


 


(b)          The
term “Board” means the Board of Directors of the Company.


 


(c)          The
term “Commission” means the United States Securities and Exchange Commission or any successor agency.


 


(d)          The
term “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
thereunder.


 


(e)          The
term “Person” (but not “person”) means any individual, firm, corporation, partnership, limited liability
company, trust or other entity, and shall include any successor (by merger or otherwise) of such entity.


 


(f)          The
term “Purchase Price” means $6.00 per Share.


 


(g)          The
term “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.


 


Any terms used in this Agreement and not
defined herein shall have the meanings given such terms in the Investment Agreement.


 


Article
II



REGISTRATION OF COMMON STOCK; INDEMNIFICATION


 


Section 2.01    
Registrable Securities. For the purposes of this Agreement, “Registrable Securities” means the
Shares; provided that (i) any Shares of Common Stock will cease to be Registrable Securities, and (ii) the Company will not be
obligated to maintain the effectiveness of the Shelf Registration Statement (as defined below), and the Company’s obligations
under Section 2.02 will cease, with respect to the Registrable Securities of a holder thereof (a “Holder”) following
the date on which (a) such securities have been sold or otherwise transferred by the Holder thereof pursuant to an effective registration
statement; or (b) such securities are sold in accordance with Rule 144 (or any successor provision) promulgated under the Securities
Act. The period of time during which the Company is required to keep the Shelf Registration Statement effective is referred to
as the “Effectiveness Period.”


 




    	 	A-2	 



     

    

 


Section 2.02    
Registration. Within ten (10) Business Days following the date on which the Company consummates the Rights Offering
and the transactions contemplated by the Investment Agreement, the Company shall prepare and file a resale registration statement
on Form S-3 or another applicable form, if Form S-3 is not then available, registering offers and sales of Registrable Securities
held by the Investor and any Affiliated Purchasers pursuant to Rule 415 under the Securities Act (such registration statement together
with all exhibits thereto and any post-effective amendment thereto that becomes effective, the “Shelf Registration Statement”).
The Company may supplement the Shelf Registration Statement from time to time to register securities other than Registrable Securities
for sale for the account of any Person; provided, however, that such supplement will be permitted only so long as
the Commission rules provide that such supplement does not give the Commission the right to review the Shelf Registration Statement;
provided, further, that such supplement does not adversely affect the rights of any Holder. Notwithstanding the foregoing
or anything to the contrary in this Article II, if the Company grants registration rights to one or more other holders of its Common
Stock that are more favorable to such holders than the registration rights granted hereunder, with respect to underwritten offerings
or otherwise, the Company and holders of a majority of the Registrable Securities hereunder shall in good faith amend this Agreement
to reflect such more favorable terms as reasonably as practicable.


 


Section 2.03    
Registration Procedures. In connection with the registration of any Registrable Securities under the Securities Act
as provided in this Article II, the Company will use its best efforts to:


 


(a)          cause
the Shelf Registration Statement (and any other related registrations, qualifications or compliances as may be reasonably requested
and as would permit or facilitate the sale and distribution of all Registrable Securities until the distribution thereof is complete)
to become effective as soon as practicable following the filing thereof but not later than 180 days after the Closing Date (the
“Scheduled Effective Date”);


 


(b)          prepare
and file with the Commission the amendments and supplements to the Shelf Registration Statement and the prospectus used in connection
therewith and take all other actions as may be necessary to keep the Shelf Registration Statement continuously effective until
the disposition of all securities in accordance with the intended methods of disposition by the Holder or Holders thereof set forth
in the Shelf Registration Statement will be completed, and to comply with the provisions of the Securities Act (to the extent applicable
to the Company) with respect to the dispositions;


 


(c)          
(i) at least five (5) Business Days before filing with the Commission, furnish to each Holder and its counsel (if any) copies of
all documents proposed to be filed with the Commission in connection with such registration, which documents will be subject to
the review and reasonable comment of such Holder and its counsel; (ii) furnish to each Holder of Registrable Securities a reasonable
number of copies of the Shelf Registration Statement, of each amendment and supplement thereto, and of the prospectus included
in the Shelf Registration Statement (including each preliminary prospectus), in conformity with the requirements of the Securities
Act, and the other documents (including exhibits to any of the foregoing), as the Holder may reasonably request, in order to facilitate
the disposition of the Registrable Securities owned by such Holder; and (iii) respond as promptly as practicable to any comments
received from the Commission with respect to each Shelf Registration Statement or any amendment thereto and, as promptly as reasonably
possible, provide the Holders true and complete copies of all correspondence from and to the Commission relating to such Shelf
Registration Statement that pertains to the Holders as “Selling Stockholders” but not any comments that would result
in the disclosure to the Holders of material and non-public information concerning the Company.


 




    	 	A-3	 



     

    

 


(d)          register
or qualify the Registrable Securities covered by the Shelf Registration Statement under the securities or “blue sky”
laws of the various states as any Holder reasonably requests and do any and all other acts and things that may be necessary or
reasonably advisable to enable a Holder to consummate the disposition in such states of the Registrable Securities owned by such
Holder, except that the Company will not be required to qualify generally to do business as a foreign corporation in any jurisdiction
wherein it would not, but for the requirements of this Section 2.03(d), be obligated to be qualified, or to subject itself to taxation
in any jurisdiction;


 


(e)          provide
a transfer agent and registrar for the Registrable Securities covered by the Shelf Registration Statement not later than the effective
date of the Shelf Registration Statement;


 


(f)          notify
the Holders promptly, and confirm such notice in writing, (i)(A) when a prospectus as contained in the Shelf Registration Statement
(a “Prospectus”) or any Prospectus supplement or post-effective amendment has been filed, and (B) with respect
to a Shelf Registration Statement or any post-effective amendment, when the same has become effective, (ii) of the issuance by
the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of a Shelf Registration
Statement or the initiation of any proceedings for that purpose, (iii) of the receipt by the Company of any notification with respect
to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction
or the initiation or threatening of any proceeding for such purpose, (iv) of the existence of any fact or the happening of any
event that makes any statement made in such Shelf Registration Statement or related Prospectus or any document incorporated or
deemed to be incorporated therein by reference untrue in any material respect or which requires the making of any changes in such
Shelf Registration Statement, Prospectus or documents so that, in the case of the Shelf Registration Statement, it will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the
statements therein not misleading, and that in the case of the Prospectus, it will not contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of
the circumstances under which they were made, not misleading, (v) of the Company’s reasonable determination that a post-effective
amendment to a Shelf Registration Statement would be appropriate, or (vi) of any request by the Commission or other governmental
authority for amendments or supplements to a Shelf Registration Statement or related Prospectus or for additional information that
pertains to the Holders as “Selling Stockholders” or the “Plan of Distribution”;


 


(g)          enter
into customary agreements (including, in the event the Holders elect to engage an underwriter in connection with the Shelf Registration
Statement, an underwriting agreement containing customary terms and conditions) and take all other actions as may be reasonably
required in order to expedite or facilitate the disposition of Registrable Securities; provided, however, that the
Company will not be liable for any underwriter’s fees, commissions and discounts or similar expenses; and


 




    	 	A-4	 



     

    

 


(h)          make
every reasonable effort to obtain the withdrawal of any order suspending the effectiveness of the Shelf Registration Statement
or any suspension of the qualification of any of the Registrable Securities for sale in any jurisdiction, at the earliest possible
time.


 


Section 2.04    
Rule 144. With a view to making available to the Holders the benefits of certain rules and regulations of the Commission
that at any time permit the sale of the Registrable Securities to the public without registration, the Company agrees to:


 


(a)          make
and keep public information available, as those terms are understood and defined in Rule 144 promulgated under the Securities Act;


 


(b)          file
with the Commission in a timely manner all reports and other documents required of the Company under the Exchange Act;


 


(c)          so
long as a Holder owns any unregistered Registrable Securities, furnish to the Holder upon any reasonable request a written statement
by the Company as to its compliance with the public information requirements of Rule 144 promulgated under the Securities Act and/or
the Exchange Act, a copy of the most recent annual or quarterly report of the Company, and any other reports and documents of the
Company as the Holder may reasonably request in availing itself of any rule or regulation of the Commission allowing a Holder to
sell any Registrable Securities without registration (excluding any reports or documents of the Company that the Company, in its
sole discretion, deems confidential); and


 


(d)          take
such further action as any Holder may reasonably request to enable such Holder to sell such Shares without registration under the
Securities Act within the limitation of the exemptions provided by Rule 144 promulgated under the Securities Act, including providing
any legal opinions relating to such sale pursuant to Rule 144.


 


Section 2.05    
Registration and Selling Expenses. All expenses incurred by the Company in connection with the Company’s performance
of or compliance with this Article II, including, without limitation, (i) all Commission registration and filing fees, (ii) blue
sky fees and expenses, (iii) all necessary printing and duplicating expenses and (iv) all fees and disbursements of counsel and
accountants retained on behalf of the Company (all expenses being called “Registration Expenses”), will be paid
by the Company. Each Holder may, at its election, retain its own counsel and other representatives and advisors as it chooses at
its own expense; provided that the Company will pay the reasonable fees and expenses of one counsel to the Holders incurred as
part of reviewing the Shelf Registration Statement and any Prospectuses and amendments related thereto.


 




    	 	A-5	 



     

    

 


Section 2.06    
Registration Statement Not Declared Effective. The Company and the Holders agree that the Holders will suffer damages
if (i) the Shelf Registration Statement is not declared effective by the Commission on or prior to the Scheduled Effective Date,
or (ii) the length or frequency of Black-Out Periods (as defined below) exceed the limits set forth in Section 2.07(a) hereof.
The Company and the Holders further agree that it would not be feasible to ascertain the extent of such damages with precision.
Accordingly, (x) if the Shelf Registration Statement is not declared effective by the Commission on or prior to the Scheduled Effective
Date and on such date or at any time thereafter the Company is not diligently and in good faith making commercially reasonable
efforts to have the Shelf Registration Statement declared effective, the Company shall pay an amount in cash as liquidated damages
to each Holder equal to one percent (1%) of the Purchase Price of the Shares held by such Holder for each thirty (30) day period
after the Scheduled Effective Date during which the Company is failing to make such efforts, up to a maximum of four percent (4%);
and (y) during the continuance of a Black-Out Period beyond the limits set forth in Section 2.07(a) hereof, the Company shall pay
an amount in cash as liquidated damages to each Holder equal to one percent (1%) of the Purchase Price of the Shares held by such
Holder for each thirty (30) day period during the continuance of a Black-Out Period beyond such limits, pro-rated as applicable
for any partial month, up to a maximum of four percent (4%).


 


Section 2.07    
Certain Obligations of Holders.


 


(a)          Each
Holder agrees that, upon receipt of any notice from the Company of (i) the happening of any event of the kind described in Sections
2.03(f)(i)(A), 2.03(f)(ii), 2.03(f)(iii), 2.03(f)(iv), 2.03(f)(v) or 2.03(f)(vi) hereof, or (ii) a determination by the
Board that it is advisable to suspend use of the Prospectus for a discrete period of time due to pending corporate developments
such as negotiation of a material transaction which the Company in its sole discretion after consultation with legal counsel, determines
it would be obligated to disclose in the Shelf Registration Statement, which disclosure the Company believes would be premature
or otherwise inadvisable at such time or would have a material adverse effect on the Company and its stockholders, such Holder
will forthwith discontinue disposition of such Registrable Securities pursuant to the Shelf Registration Statement or Prospectus
until such Holder’s receipt of the copies of the supplemented or amended Prospectus contemplated by Section 2.03(b) hereof,
or until such Holder is advised in writing by the Company that the use of the applicable Prospectus may be resumed and has received
copies of any additional or supplemental filings that are incorporated or deemed to be incorporated by reference in such Prospectus.
The period of time in which the use of a Prospectus or Shelf Registration Statement is so suspended shall be referred to as a “Black-Out
Period.” The Company agrees to so advise such Holder promptly of the commencement and termination of any such Black-Out
Period, and the Purchasers agree to keep the fact of such Black-Out Period confidential. The Company shall not impose a Black-Out
Period under this Section 2.07 for more than ninety (90) consecutive days and not more than twice in any given twelve (12) month
period; provided, that at least sixty (60) days must pass between Black-Out Periods and the total aggregate length of all Black-Out
periods within any twelve (12) month period shall not exceed one hundred and twenty (120) days. Notwithstanding the foregoing,
the Company may suspend use of any Shelf Registration Statement if the Commission’s rules and regulations prohibit the Company
from maintaining the effectiveness of a Shelf Registration Statement because its financial statements are stale at a time when
its fiscal year has ended or it has made an acquisition reportable under Item 2.01 of Form 8-K or any other similar situation until
the Company’s Form 10-K has been filed or a Form 8-K, including any required pro forma or historical financial statements,
has been filed, respectively (provided that the Company shall use its reasonable best efforts to cure any such situation as soon
as possible so that the Shelf Registration Statement can be used at the earliest possible time).


 




    	 	A-6	 



     

    

 


(b)          As
a condition to the closing and to the inclusion of its Registrable Securities, each Holder will furnish to the Company the information
regarding the Holder as is legally required in connection with any registration, qualification or compliance referred to in this
Article II.


 


(c)          Each
Holder hereby covenants with the Company not to make any sale of the Registrable Securities pursuant to the Shelf Registration
Statement without effectively causing the prospectus delivery requirements under the Securities Act to be satisfied.


 


(d)          Each
Holder acknowledges and agrees that the Registrable Securities sold pursuant to the Shelf Registration Statement are not transferable
on the books of the Company unless the stock certificate submitted to the transfer agent evidencing the Registrable Securities,
if applicable, is accompanied by a certificate reasonably satisfactory to the Company to the effect that (i) the Registrable Securities
have been sold in accordance with this Agreement and the Shelf Registration Statement and (ii) the requirement of delivering a
current prospectus has been satisfied.


 


(e)          Each
Holder is hereby advised that the anti-manipulation provisions of Regulation M under the Exchange Act may apply to sales of the
Registrable Securities offered pursuant to the Shelf Registration Statement and agrees not to take any action with respect to any
distribution deemed to be made pursuant to the Shelf Registration Statement that constitutes a violation of Regulation M under
the Exchange Act or any other applicable rule, regulation or law.


 


(f)          [Intentionally
omitted].


 


(g)          The
rights to cause the Company to register Registrable Securities granted to the Holders by the Company under Section 2.02 may
be assigned in whole or in part by a Holder in connection with the transfer of such Registrable Securities, provided, that: (i)
the transfer of the Registrable Securities and the rights to register such Registrable Securities are effected in accordance with
applicable securities laws, (ii) the transfer involves not less than fifty percent (50%) of the Shares, (iii) the Holder gives
prior written notice to the Company, and (iv) the transferee agrees to comply with the terms and provisions of this Agreement in
a written instrument reasonably satisfactory in form and substance to the Company and its counsel. Except as specifically permitted
by this Section 2.07, the rights of a Holder with respect to Registrable Securities will not be transferable to any other Person,
and any attempted transfer will cause all rights of the Holder to registration of Registrable Securities under this Article II
to be forfeited, void ab initio and of no further force and effect.


 


(h)          With
the written consent of the Company and each Holder affected or potentially affected by such proposed waiver, any provision of Sections
2.01, 2.02, 2.03, 2.04, 2.05, 2.06, 2.07 or 2.08 may be waived (either generally or in a particular instance, either retroactively
or prospectively and either for a specified period of time or indefinitely). Upon the effectuation of each waiver, the Company
will promptly give written notice thereof to such Holders.


 




    	 	A-7	 



     

    

 


Section 2.08    
Indemnification.


 


(a)          By
the Company. The Company agrees to indemnify, to the fullest extent permitted by law, each Holder of Registrable Securities
being sold, its directors, officers, employees, members, managers, partners, agents, and each other Person, if any, who controls
(within the meaning of the Securities Act and the rules and regulations thereunder) such Holder (each, an “Indemnified
Person”) against all losses, claims, damages, liabilities, and expenses (including legal fees and expenses and all costs
incident to investigation or preparation with respect to such losses, claims, damages, liabilities, and expenses and to reimburse
such Indemnified Person for such costs as incurred) (collectively, the “Losses”) caused by, resulting from,
or relating to any untrue or alleged untrue statement of material fact contained in the Shelf Registration Statement, prospectus,
or preliminary prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact
required to be stated therein or a fact necessary to make the statements therein not misleading, except insofar as the same are
caused by or contained in any information furnished to the Company by or on behalf of such Holder in writing expressly for use
therein or by such Holder’s failure to deliver a copy of the Shelf Registration Statement or prospectus or any amendments
or supplements thereto after the Company has furnished such Holder with a sufficient number of copies of the same and notified
such Holder of such obligation. In connection with an underwritten offering and without limiting any of the Company’s other
obligations under this Agreement, the Company shall indemnify such underwriters, their officers, directors, employees, and agents
and each Person who controls (within the meaning of the Securities Act and the rules and regulations thereunder) such underwriters
or such other indemnified Person to the same extent as provided above with respect to the indemnification of the Holders of Registrable
Securities being sold.


 


(b)          By
the Investor. In connection with any registration statement in which a Holder of Registrable Securities is participating pursuant
to this Agreement, each such Holder will, if requested, furnish to the Company in writing information regarding such Holder’s
ownership of Registrable Securities and, to the extent permitted by law, shall, severally and not jointly, indemnify the Company,
its directors, and each Person who controls (within the meaning of the Securities Act and the rules and regulations thereunder)
the Company against all Losses caused by, resulting from, or relating to any untrue or alleged untrue statement of material fact
contained in the Shelf Registration Statement, prospectus, or preliminary prospectus or any amendment thereof or supplement thereto
or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein
not misleading, but only to the extent that such untrue statement or omission is caused by and contained in such information so
furnished to the Company in writing by or on behalf of such Holder expressly for use therein; provided, however,
that each Holder’s obligation to indemnify the Company hereunder shall be apportioned between each Holder based upon the
net amount received by each Holder from the sale of Registrable Securities, as compared to the total net amount received by all
of the Holders of Registrable Securities sold pursuant to such registration statement, no such Holder being liable to the Company
in excess of such apportionment; and provided, further (i) that each Holder’s obligation to indemnify the Company
hereunder shall be apportioned between each Holder as is appropriate to reflect the relative fault of such Holder on the one hand,
and of each other Holder on the other, in connection with the statements or omissions that resulted in such Losses. The relative
fault of each Holder on the one hand, and each other Holder on the other, shall be determined by reference to, among other things,
whether any untrue or any alleged untrue statement of a material fact or the omission or alleged omission to state a material fact
relates to information supplied by such Holder and the parties’ relevant intent, knowledge, information and opportunity to
correct or prevent such statement or omission.


 




    	 	A-8	 



     

    

 


(c)          Notice.
Any Person entitled to indemnification hereunder shall give prompt written notice to the indemnifying party of any claim with respect
to which its seeks indemnification; provided, however, that the failure to give such notice shall not release the indemnifying
party from its obligation, except to the extent that the indemnifying party has been materially prejudiced by such failure to provide
such notice.


 


(d)          Defense
of Actions. In any case in which any such action is brought against any indemnified party and it notifies an indemnifying party
of the commencement thereof, the indemnifying party will be entitled to participate therein and, to the extent that it may wish,
jointly with any other indemnifying party similarly notified, to assume the defense thereof, with counsel reasonably satisfactory
to such indemnified party, and, after notice from the indemnifying party to such indemnified party of its election so to assume
the defense thereof, the indemnifying party will not (so long as it shall continue to have the right to defend, contest, litigate,
and settle the matter in question in accordance with this paragraph) be liable to such indemnified party hereunder for any legal
or other expense subsequently incurred by such indemnified party in connection with the defense thereof other than reasonable costs
of investigation, supervision, and monitoring (unless such indemnified party reasonably objects to such assumption on the grounds
that there may be defenses available to it that are different from or in addition to the defenses available to such indemnifying
party or if a conflict or potential conflict of interest exists, in either of which event the indemnified party shall be reimbursed
by the indemnifying party for the expenses incurred in connection with retaining separate legal counsel). An indemnifying party
shall not be liable for any settlement of an action or claim effected without its consent, which consent shall not be unreasonably
withheld, conditioned or delayed. The indemnifying party shall lose its right to defend, contest, litigate, and settle a matter
if it shall fail diligently to contest such matter (except to the extent settled in accordance with the next following sentence).
No matter shall be settled by an indemnifying party without the consent of the indemnified party (which consent shall not be unreasonably
withheld, conditioned or delayed). The indemnifying party shall not, without the prior written consent of an indemnified party
(which consent shall not be unreasonably withheld, conditioned or delayed), effect any settlement of any pending or threatened
proceedings in respect of which indemnity has been sought hereunder by such indemnified party unless (i) such settlement includes
an unconditional release of such indemnified party in form and substance satisfactory to such indemnified party from all liability
on the claims that are the subject matter of such proceedings and (ii) such settlement does not include any statement as to or
any admission of fault, culpability or a failure to act by or on behalf of any indemnified party.


 




    	 	A-9	 



     

    

 


(e)          Jointly
Indemnifiable Claims. Given that an Indemnified Person may be entitled to indemnification (a “Jointly Indemnifiable
Claim”) from both the Company, pursuant to this Agreement, and from any other Person, whether pursuant to applicable
law, any indemnification agreement, the organizational documents of such Person or otherwise (the “Indemnitee-Related
Entities”), the Company acknowledges and agrees that the Company shall be fully and primarily responsible for the payment
to the Indemnified Person in respect of indemnification and advancement of expenses in connection with any such Jointly Indemnifiable
Claim, pursuant to and in accordance with the terms of this Agreement, irrespective of any right of recovery the Indemnified Person
may have from the Indemnitee-Related Entities. Under no circumstance shall the Company be entitled to any right of subrogation
or contribution by the Indemnitee-Related Entities and no right of recovery the Indemnified Person may have from the Indemnitee-Related
Entities shall reduce or otherwise alter the rights of the Indemnified Person or the obligations of the Company hereunder. In the
event that any of the Indemnitee-Related Entities shall make any payment to the Indemnified Person in respect of indemnification
or advancement of expenses with respect to any Jointly Indemnifiable Claim, the Indemnitee-Related Entity making such payment shall
be subrogated to the extent of such payment to all of the rights of recovery of the Indemnified Person against the Company, and
the Indemnified Person shall execute all papers reasonably required and shall do all things that may be reasonably necessary to
secure such rights, including the execution of such documents as may be necessary to enable the Indemnitee-Related Entities effectively
to bring suit to enforce such rights. Each of the Indemnitee-Related Entities shall be third-party beneficiaries with respect to
this Section 2.08(e), entitled to enforce this Section 2.08(e) against the Company as though each such Indemnitee-Related
Entity were a party to this Agreement.


 


(f)          Survival.
The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made
by or on behalf of the indemnified Person and will survive the transfer of the Registrable Securities and the termination of this
Agreement.


 


(g)          Contribution.
If recovery is not available under the foregoing indemnification provisions for any reason or reasons other than as specified therein,
any Person who would otherwise be entitled to indemnification by the terms thereof shall nevertheless be entitled to contribution
with respect to any Losses with respect to which such Person would be entitled to such indemnification but for such reason or reasons.
In determining the amount of contribution to which the respective Persons are entitled, there shall be considered the Persons’
relative knowledge and access to information concerning the matter with respect to which the claim was asserted, the opportunity
to correct and prevent any statement or omission, and other equitable considerations appropriate under the circumstances, including
the relative fault of such Person, in connection with the statements or omissions that resulted in Losses. The relative fault of
each Person shall be determined by reference to, among other things, whether any untrue or any alleged untrue statement of a material
fact or the omission or alleged omission to state a material fact relates to information supplied by such Person and the parties’
relevant intent, knowledge, information and opportunity to correct or prevent such statement or omission. It is hereby agreed that
it would not necessarily be equitable if the amount of such contribution were determined by pro rata or per capita allocation.
No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled
to contribution from any Person who was not guilty of such fraudulent misrepresentation. Notwithstanding the foregoing, the Investor
and any Affiliate of such Investor shall not be required to make a contribution in excess of (i) the net amount received by such
Investor (or its Affiliate) from the sale of Registrable Securities.


 




    	 	A-10	 



     

    

 


Article
III


 

Miscellaneous


 


Section
3.01     Inconsistent Agreements.  Without the prior written consent of the Investor, the Company shall not enter into
any registration rights agreement that conflicts, or is inconsistent, with the provisions of Article II hereof.


 


Section
3.02     Specific Performance. Each of the Investor and the Company acknowledge and agree that, in the event of any breach
of this Agreement, the non-breaching party or parties would be irreparably harmed and could not be made whole by monetary damages.
The Investor and the Company hereby agree that, in addition to any other remedy to which the Investor may be entitled at law or
in equity, the Investor shall be entitled to compel specific performance of this Agreement in any action instituted in any court
of the United States or any state thereof having subject matter jurisdiction for such action.


 


Section
3.03     Headings. The headings in this Agreement are for convenience of reference only and shall not control or affect
the meaning or construction of any provisions hereof.


 


Section
3.04    Entire Agreement. Except for the Investment Agreement, this Agreement (a) constitutes the entire agreement and
understanding of the parties hereto in respect of the subject matter contained herein, and there are no restrictions, promises,
representations, warranties, covenants, conditions, or undertakings with respect to the subject matter hereof, other than those
expressly set forth or referred to herein, and (b) amends and supersedes all prior agreements and understandings between the parties
hereto with respect to the subject matter hereof.


 


Section
3.05     Notices. All notices and other communications hereunder shall be in writing and shall be delivered personally,
by next-day courier, by electronic or facsimile transmission, or telecopied with confirmation of receipt to the parties at the
addresses specified below (or at such other address for a party as shall be specified by like notice; provided that notices of
change of address shall be effective only upon receipt thereof). Any such notice shall be effective upon receipt, if personally
delivered, delivered by electronic or facsimile transmission, or telecopied, or one day after delivery to a courier for next-day
delivery.


 


If to the Company, to:


 


Trinity Place Holdings Inc.

717 Fifth Avenue, Suite 1303

New York, New York 10022

Attention: Chief Executive Officer and Chief Financial Officer

Fax: (212) 235-2199


Email: matt.messinger@tphs.com and richard.pyontek@tphs.com


 


with a copy (which shall not constitute notice) to:


 


Kramer Levin Naftalis & Frankel LLP

1177 Avenue of the Americas

New York, NY 10036

Attention: John Bessonette

Fax: (212) 715-8044

Email: jbessonette@kramerlevin.com


 




    	 	A-11	 



     

    

 


If to the Investor or the Holder(s), to:


 


MFP Partners, L.P.

c/o MFP Investors LLC

667 Madison Avenue, 25th Floor

Attention: Timothy E. Ladin

Fax: (212) 752-7265

Email: tladin@mfpllc.com


 


Section
3.06     Applicable Law. The substantive laws of the State of New York shall govern the interpretation, validity, and
performance of the terms of this Agreement, regardless of the law that might be applied under applicable principles of conflicts
of laws.


 


Section
3.07     Severability. The invalidity, illegality, or unenforceability of one or more of the provisions of this Agreement
in any jurisdiction shall not affect the validity, legality, or enforceability of the remainder of this Agreement in such jurisdiction
or the validity, legality, or enforceability of this Agreement, including any such provision, in any other jurisdiction, it being
intended that all rights and obligations of the parties hereunder shall be enforceable to the fullest extent permitted by law.


 


Section
3.08     Successors; Assigns. The provisions of this Agreement shall be binding upon the parties hereto and their respective
heirs, successors, and permitted assigns, including, without limitation and without the need for an express assignment or assumption,
any successor in interest to an Investor, whether by a sale of all or substantially all of its assets, merger, consolidation, or
otherwise. Neither this Agreement nor the rights or obligations of any party hereunder may be assigned, except as otherwise provided
in this Agreement. Any such attempted assignment in contravention of this Agreement shall be void and of no effect.


 


Section
3.09     No Third-Party Beneficiaries. Nothing in this Agreement creates in any Person not a party to this Agreement
(other than permitted assignees and a Person indemnified pursuant to Section 2.08 hereof with respect to such indemnification rights
and any Holders of the Registrable Securities with respect to the rights to which they are entitled hereunder ) any legal or equitable
right, remedy or claim under this Agreement, and this Agreement is for the exclusive benefit of the parties hereto.


 


Section
3.10     Amendments. This Agreement may not be amended, modified, or supplemented unless such modification is in writing
and signed by the Company and each Investor.


 


Section
3.11     Waiver. Any waiver (express or implied) of any default or breach of this Agreement shall not constitute a waiver
of any other or subsequent default or breach.


 


Section
3.12     Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original
but all of which shall constitute one and the same Agreement.


 




    	 	A-12	 



     

    

 


[SIGNATURE PAGE FOLLOWS]


 



    	 	A-13	 



     

    




 


IN WITNESS WHEREOF, the
undersigned hereby agree to be bound by the terms and provisions of this Registration Rights Agreement as of the date first above
written.


 


	 	TRINITY PLACE HOLDINGS INC.
	 	 	 
	 	By:	 
	 	Name:	Matthew Messinger
	 	Title:	President and Chief Executive Officer
	 	 	 
	 	MFP PARTNERS, L.P.
	 	By:	MFP Investors LLC,
	 	 	its General Partner
	 	 	 
	 	By:	 
	 	Name:	Timothy Ladin
	 	Title:	General Counsel


 


[Signature Page to Registration Rights Agreement]